TW201908303A - Pyridine compound and its use - Google Patents

Pyridine compound and its use

Info

Publication number
TW201908303A
TW201908303A TW106124227A TW106124227A TW201908303A TW 201908303 A TW201908303 A TW 201908303A TW 106124227 A TW106124227 A TW 106124227A TW 106124227 A TW106124227 A TW 106124227A TW 201908303 A TW201908303 A TW 201908303A
Authority
TW
Taiwan
Prior art keywords
substituted
unsubstituted
group
alkyl
alkoxy
Prior art date
Application number
TW106124227A
Other languages
Chinese (zh)
Inventor
寺西貴昭
植薄信也
岩田淳
鎌田拓也
宗井陽平
西村聡
井上生
田中哲也
中村優花
福島悠介
小林朝巳
幸堀伸哉
Original Assignee
日商日本曹達股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日本曹達股份有限公司 filed Critical 日商日本曹達股份有限公司
Priority to TW106124227A priority Critical patent/TW201908303A/en
Publication of TW201908303A publication Critical patent/TW201908303A/en

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The present invention provides a pyridine compound represented by formula (I) (wherein R1 to R4 each represent a hydrogen atom, an unsubstituted or G1-subsutituted C1-6 alkyl group or the like, A represents an oxygen atom or the like, Cy represents a C6-10 aryl group or the like), an N-oxide compound thereof, or a tautomer or salt thereof. The present invention also provides a fungicide for agricultural and horticultural use, a harmful organism control agent, and insecticide or acaricide including at least one selected from the group consisting of a compound represented by formula (I), and a tautomer and salt thereof as an active ingredient.

Description

吡啶化合物及其用途    Pyridine compounds and uses thereof   

本發明係關於一種吡啶化合物、以及農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑等之用途。 The present invention relates to the use of a pyridine compound, fungicides for agricultural and horticultural purposes, pest control agents, and insecticides or acaricides.

於栽培農園藝作物時,針對作物之病害提出有大量防除藥劑。所提出之防除藥劑中之大部分因如下原因而並非可充分令人滿意者:其防除效力不充分;或由於出現抗藥性之病原菌導致其使用受到限制;或會對植物體產生藥害或污染;或者對人畜魚類之毒性或對環境之影響大等。因此,強烈希望出現該缺陷少之可安全使用之防除藥劑。 In the cultivation of agricultural and horticultural crops, a large number of pesticides have been proposed for the diseases of the crops. Most of the proposed control agents are not fully satisfactory for the following reasons: their control effectiveness is insufficient; or their use is restricted due to the emergence of drug-resistant pathogenic bacteria; or they may cause phytotoxicity or pollution to the plant body ; Or the toxicity to humans, animals and fish or the impact on the environment. Therefore, there is a strong desire for a safe useable control agent with few such defects.

且說,於專利文獻1中揭示有一種式(1)或式(2)表示之化合物。根據專利文獻1,該化合物似乎作為電子傳遞系之複合體II抑制劑有用。 In addition, Patent Document 1 discloses a compound represented by formula (1) or formula (2). According to Patent Document 1, the compound appears to be useful as a complex II inhibitor of an electron transport system.

又,於非專利文獻1中揭示有一種式(3)表示之化合物。根據非專利文獻1,該化合物似乎作為抗瘧疾劑有用。 In addition, Non-Patent Document 1 discloses a compound represented by the formula (3). According to Non-Patent Document 1, this compound seems to be useful as an antimalarial agent.

又,於非專利文獻2中揭示有一種式(4)表示之化合物。根據非專利文獻2,該化合物似乎具有哺乳動物及菌之複合物II(complex II)之阻礙活性。 In addition, Non-Patent Document 2 discloses a compound represented by the formula (4). According to Non-Patent Document 2, the compound appears to have a mammalian-bacterial complex II inhibitory activity.

[專利文獻1]WO 2003/103667 A [Patent Document 1] WO 2003/103667 A

[非專利文獻1]J.Med.Chem.2008, 51, 2845-2852 [Non-Patent Document 1] J. Med. Chem. 2008, 51, 2845-2852

[非專利文獻2]Bioorg.Med.Chem.Lett.2010, 20, 1665-1668 [Non-Patent Document 2] Bioorg. Med. Chem. Lett. 2010, 20, 1665-1668

本發明之課題在於提供一種新穎之吡啶化合物、以及農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑。 An object of the present invention is to provide a novel pyridine compound, a fungicide for agriculture and horticulture, a pest control agent, and an insecticide or acaricide.

為了解決上述課題而進行了研究,結果完成包含以下之態樣之本發明。 In order to solve the problems described above, the present invention has been completed including the following aspects.

[1]一種吡啶化合物、其N-氧化物化合物、或者其互變異構物或鹽,該吡啶化合物係以式(I)表示, [1] A pyridine compound, an N-oxide compound thereof, or a tautomer or salt thereof, the pyridine compound is represented by formula (I),

式(I)中,R1表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C1~6烷氧基、未經取代或經G1取代之C1~6烷氧基羰基、未經取代或經G1取代之C1~6烷硫基(alkylthio group)、未經取代或經G1取代之C1~6烷基胺基羰基、未經取代或經G2取代之C6~10芳基、氰基或鹵素基(halogeno group); 式(I)中,R2表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G2取代之C3~8環烷基、未經取代或經G1取代之C1~6烷氧基、甲醯氧基、未經取代或經G1取代之C1~6烷基羰氧基、未經取代或經G2取代之C6~10芳基、(未經取代或經G1取代之C1~6烷氧基亞胺基)-C1~6烷基、未經取代或經G2取代之3~10員雜環基C1~6烷基、氰基或鹵素基;式(I)中,R3表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G2取代之C3~8環烷基、未經取代或經G1取代之C1~6烷氧基、未經取代或經G1取代之C1~6烷基羰基、未經取代或經G1取代之C1~6烷氧基羰基、羧基、甲醯基、甲醯氧基、未經取代或經G1取代之C1~6烷基羰氧基、未經取代或經G2取代之C6~10芳基、未經取代或經G2取代之3~10員雜環基、(未經取代或經G1取代之C1~6烷氧基亞胺基)-C1~6烷基、未經取代或經G1取代之單C1~6烷基胺基、未經取代或經G1取代之二C1~6烷基胺基、氰基或鹵素基;式(I)中,R4表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G2取代之C3~8環烷基、未經取代或經G2取代之C6~10芳基C1~6烷基、未經取代或經G2取代之3~10員雜環基C1~6烷基、甲醯基、未經取代或經G1取代之C1~6烷基羰基、未經取代或經G2取代之C3~8環烷基羰基、未經取代或經G1取代之C2~6烯基羰基、未經取代或經G2取代之C6~10芳基羰基、未經取代或經G1取代之C1~6烷氧基羰基、未經取代或經G1取代之C2~6烯氧基羰基、未經取代或經G1取代之C1~6烷基磺醯 基、未經取代或經G1取代之C1~6烷基胺基羰基、未經取代或經G1取代之(C1~6烷硫基)羰基、未經取代或經G1取代之C1~6烷基胺基(硫羰基)、或者式(II)表示之有機基; In formula (I), R 1 represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1 to 6 alkyl group, an unsubstituted or G 1 substituted C 2 to 6 alkenyl group, an unsubstituted or G 1 substituted C1 ~ 6 alkoxy, unsubstituted or G 1 substituted C1 ~ 6 alkoxycarbonyl, unsubstituted or G 1 substituted C1 ~ 6 alkylthio group, unsubstituted or G 1 substituted C1 ~ 6 alkylaminocarbonyl, unsubstituted or G 2 substituted C6 ~ 10 aryl, cyano or halogeno group; in formula (I), R 2 represents a hydrogen atom, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl, unsubstituted or substituted with G 1 of C2 ~ 6 alkenyl, unsubstituted or substituted with G 2 of C3 ~ 8 cycloalkyl, unsubstituted or C1 ~ 6 alkoxy substituted with G 1 , methyloxy, unsubstituted or substituted G 1-6 alkylcarbonyloxy, unsubstituted or substituted G 2- C 6-10 aryl, (C1-C6 alkoxyimino group, unsubstituted or substituted with G 1 ) -C1-6 alkyl group, 3 to 10-membered heterocyclic C1- 6 alkyl group, unsubstituted or G 2 substituted, cyano Or a halogen group; in the formula (I), R 3 represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1 to 6 alkyl group, an unsubstituted or G 1 substituted C 2 to 6 alkene Group, unsubstituted or G 2 substituted C3-8 cycloalkyl, unsubstituted or G 1 substituted C1-6 alkoxy, unsubstituted or G 1 substituted C1-6 alkylcarbonyl, C1 ~ 6 alkoxycarbonyl, unsubstituted or G 1 substituted, carboxyl, formamyl, formamyloxy, unsubstituted or G 1 substituted C1 ~ 6 alkylcarbonyloxy, unsubstituted or the G 2 substituted by C6 ~ 10 aryl group, unsubstituted or substituted by the G 2 3 ~ 10 membered heterocyclic group, (unsubstituted or substituted with G 1 of C1 ~ 6 alkoxyimino group) -C1 ~ 6 alkyl, unsubstituted or G 1 substituted mono C1 ~ 6 alkylamino, unsubstituted or G 1 substituted C1 ~ 6 alkylamino, cyano or halogen group; formula (I ), R 4 represents a hydrogen atom, an unsubstituted or G 1 -substituted C1 to 6 alkyl group, an unsubstituted or G 1 substituted C 2 to 6 alkenyl group, an unsubstituted or G 1 substituted C 2 to 6 6 alkynyl, unsubstituted or G 2 substituted C3-8 cycloalkyl, unsubstituted or G 2 substituted C6-10 aryl C1-6 alkyl, unsubstituted or G 2 substituted 3 to 10-membered heterocyclic group C1 ~ 6 alkyl group, methyl acyl, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl carbonyl, unsubstituted or substituted with G 2 of C3 ~ 8 cycloalkyl Group, unsubstituted or substituted with G 1 of C2 ~ 6 alkenyl-carbonyl, unsubstituted or substituted with G 2 of the C6 ~ 10 aryl-carbonyl group, unsubstituted or substituted with G 1 of C1 ~ 6 alkoxycarbonyl , unsubstituted or G 1 of C2 ~ 6 alkenyl substituted oxycarbonyl group, unsubstituted or substituted with G 1 of C1 ~ 6 alkylsulfonyl group, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl aminocarbonyl, unsubstituted or substituted with 1 G of (C1 ~ 6 alkylthio) carbonyl group, a substituted or unsubstituted of C1 ~ 6 alkylamino (thiocarbonyl group) by G, or of formula (II), Of organic

式(II)中,*表示鍵結鍵;式(II)中,Ga分別獨立地表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G2取代之C3~8環烷基、或者未經取代或經G2取代之C6~10芳基;式(II)中,Gb表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G2取代之C3~8環烷基、未經取代或經G2取代之C6~10芳基、或者未經取代或經G2取代之3~10員雜環基;式(II)中,T表示氧原子、氧基羰基、羰氧基、氧基羰氧基、硫原子、(硫基)羰基、羰基(硫基)、(硫基)羰氧基、氧基羰基(硫基)或-O-C(=O)-N(Gb)-表示之二價基;式(I)中,A表示氧原子或式(III)表示之二價有機基; In formula (II), * represents a bonding bond; in formula (II), G a each independently represents a hydrogen atom, an unsubstituted or G 1 -substituted C1 to 6 alkyl group, unsubstituted or substituted with G 1 C2 ~ 6 alkenyl, unsubstituted or G 1 substituted C2 ~ 6 alkynyl, unsubstituted or G 2 substituted C3 ~ 8 cycloalkyl, or unsubstituted or G 2 substituted C6 ~ 10 aryl groups; in the formula (II), G b represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1 to 6 alkyl group, an unsubstituted or G 1 substituted C 2 to 6 alkenyl group, an unsubstituted or substituted by G 1 group of C2 ~ 6 alkynyl, unsubstituted or substituted with G 2 of C3 ~ 8 cycloalkyl, unsubstituted or substituted with G 2 of the C6 ~ 10 aryl group, or unsubstituted or G 2 Substituted 3 to 10-membered heterocyclic groups; in formula (II), T represents an oxygen atom, an oxycarbonyl group, a carbonyloxy group, an oxycarbonyloxy group, a sulfur atom, a (thio) carbonyl group, a carbonyl (thio) group, (Thio) carbonyloxy, oxycarbonyl (thio), or a divalent group represented by -OC (= O) -N (G b )-; in formula (I), A represents an oxygen atom or formula (III) Represents a divalent organic group;

式(III)中,*表示鍵結位置;式(III)中,R5及R6分別獨立地表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C1~6烷氧基、未經取代或經G2取代之C6~10芳氧基、未經取代或經G1取代之烷氧基羰氧基、鹵素基、羥基;R5及R6可相連而與R5及R6所鍵結之碳原子一起形成3~6員環;式(I)中,Cy表示未經取代或經G2取代之C6~10芳基、經G2取代之C3~8環烷基、未經取代或經G2取代之3~10員雜環基、或13員雜芳基;G1表示羥基、C1~6烷氧基、C1~6烷氧基C1~6烷氧基、C1~6烷氧基羰基、甲醯氧基、C1~6烷基羰氧基、C1~6烷氧基羰氧基、單C1~6烷氧基羰基胺基、氰基、胺基或鹵素基;於經G1取代之基存在2個以上之情形時,該G1互相可相同,亦可不同;G2表示未經取代或經G21取代之C1~8烷基、未經取代或經G21取代之C2~6烯基、未經取代或經G21取代之C2~6炔基、羥基、未經取代或經G21取代之C1~6烷氧基、甲醯基、未經取代或經G21取代之C1~6烷基羰基、未經取代或經G21取代之C1~6烷氧基羰基、甲醯氧基、未經取代或經G21取代之C1~6烷基羰氧基、甲醯基胺基、未經取代或經G21取代之單C1~6烷基羰基胺基、未經取代或經G21取代之N-(C1~6烷基羰基)-N-(C1~6烷基)胺基、未經取代或經G21取代之N-(C1~6烷基羰基)-N-(C1~6烷氧基羰基)胺基、未經取代或經G21取代之C1~6烷氧基羰氧基、未經取代或經G21取 代之單C1~6烷氧基羰基胺基、未經取代或經G22取代之C3~8環烷基、未經取代或經G22取代之C3~8環烯基、未經取代或經G22取代之C3~8環烷基羰基胺基羰基、未經取代或經G22取代之C6~10芳基、未經取代或經G22取代之C6~10芳基C2~6炔基、未經取代或經G22取代之C6~10芳氧基、未經取代或經G22取代之3~10員雜環基、13員雜芳基、未經取代或經G22取代之3~10員雜環氧基、巰基、未經取代或經G21取代之C1~6烷硫基、未經取代或經G21取代之C1~6烷基亞磺醯基、未經取代或經G21取代之C1~6烷基磺醯基、五氟硫基(pentafluorosulfanyl group)、未經取代或經G22取代之C6~10芳硫基、未經取代或經G22取代之C6~10芳基亞磺醯基、未經取代或經G22取代之C6~10芳基磺醯基、未經取代或經G22取代之單C6~10芳基胺基、二氫氧硼基(dihydroboryl group)、硝基、氰基、鹵素基、未經取代或經G21取代之C1~6伸烷基(alkylene group)、未經取代或經G21取代之C1~6伸烷基單氧基、未經取代或經G21取代之C1~6伸烷基二氧基、-CRa=NRb表示之基;此處,Ra表示氫原子、C1~6烷基、未經取代或經G21取代之單C1~6烷基羰基胺基、或者未經取代或經G22取代之單C3~8環烷基羰基胺基,Rb表示未經取代或經G21取代之C1~6烷氧基、未經取代或經G22取代之C3~8環烷氧基、未經取代或經G22取代之苯氧基、未經取代或經G21取代之單C1~6烷基胺基、或者未經取代或經G21取代之二C1~6烷基胺基;於經G2取代之基存在2個以上之情形時,該G2互相可相同,亦可不同;G21表示C1~6烷氧基、C1~6鹵化烷氧基、單C1~6烷基胺基、二C1~6烷基胺基、單(C1~6烷氧基C1~6烷基羰基)胺基、未經取代或經G211 取代之C6~10芳基、未經取代或經G211取代之C6~10芳氧基、未經取代或經G211取代之3~10員雜環基、未經取代或經G211取代之3~10員雜環氧基或鹵素基;於經G21取代之基存在2個以上之情形時,該G21互相可相同,亦可不同;G211表示C1~6烷基、C1~6鹵化烷基、C1~6烷氧基、C1~6鹵化烷氧基或鹵素基;於經G211取代之基存在2個以上之情形時,該G211互相可相同,亦可不同;G22表示未經取代或經羥基取代之C1~6烷基、C1~6鹵化烷基、C2~6烯基、C2~6鹵化烯基、C2~6炔基、C1~6烷氧基、C1~6鹵化烷氧基、C1~6烷基羰基、單C1~6烷基胺基、二C1~6烷基胺基、C1~6烷基胺基羰基、C1~6烷硫基、C1~6鹵化烷硫基、C1~6烷基亞磺醯基、C1~6鹵化烷基亞磺醯基、C1~6烷基磺醯基、C1~6鹵化烷基磺醯基、未經取代或經G221取代之C3~8環烷基、未經取代或經G221取代之C3~8環烷基C1~6烷基、未經取代或經G221取代之C6~10芳基、未經取代或經G221取代之3~10員雜環基、未經取代或經G221取代之3~10員雜環基羰基、五氟硫基、硝基、氰基、鹵素基、側氧基、未經取代或經G211取代之C1~6伸烷基二氧基、或-CRc=NORd表示之基;此處,Rc表示C1~6烷基,Rd表示未經取代或經G221取代之C3~8環烷基;於經G22取代之基存在2個以上之情形時,該G22互相可相同,亦可不同;G221表示C1~6烷基、C1~6鹵化烷基、C1~6烷氧基、C1~6鹵化烷氧基、單C1~6烷基胺基、二C1~6烷基胺基、C6~10芳基或鹵素基;於經G221取代之基存在2個以上之情形時,該G221互相可相同,亦可不同。 In formula (III), * represents a bonding position; in formula (III), R 5 and R 6 each independently represent a hydrogen atom, an unsubstituted or G 1 -substituted C1 to 6 alkyl group, an unsubstituted or G 1 substituted C1 ~ 6 alkoxy, unsubstituted or G 2 substituted C6 ~ 10 aryloxy, unsubstituted or G 1 substituted alkoxycarbonyloxy, halo, hydroxyl; R 5 And R 6 may be connected to form a 3- to 6-membered ring together with the carbon atoms bonded to R 5 and R 6 ; in the formula (I), Cy represents an unsubstituted or G 2 substituted C 6-10 aryl group, G 2 substituted C3-8 cycloalkyl, unsubstituted or G 2 substituted 3- to 10-membered heterocyclyl, or 13-membered heteroaryl; G 1 represents hydroxyl, C1 to 6 alkoxy, and C1 to 6 Alkoxy C1 ~ 6 alkoxy, C1 ~ 6 alkoxycarbonyl, formamyloxy, C1 ~ 6 alkylcarbonyloxy, C1 ~ 6 alkoxycarbonyloxy, mono C1 ~ 6 alkoxycarbonyl Amine group, cyano group, amino group or halogen group; when there are two or more groups substituted with G 1 , the G 1 may be the same as or different from each other; G 2 represents an unsubstituted or G 21 substituted group C1 ~ 8 alkyl, unsubstituted or substituted with the G 21 C2 ~ 6 alkenyl, unsubstituted or substituted with G 21 of C2 ~ 6 alkynyl group, a hydroxyl group, without A substituted or is substituted by G of 21 C1 ~ 6 alkoxy, methyl acyl, unsubstituted or substituted with G 21 of C1 ~ 6 alkyl carbonyl, unsubstituted or substituted with G 21 of C1 ~ 6 alkoxycarbonyl Methylformyloxy, unsubstituted or G 21 substituted C1 ~ 6 alkylcarbonyloxy, methylamino, unsubstituted or substituted with G 21 mono C1 ~ 6 alkylcarbonylamino, unsubstituted substituted or unsubstituted by the G 21 N- (C1 ~ 6 alkyl-carbonyl) -N- (C1 ~ 6 alkyl) amino, unsubstituted or substituted with the G 21 N- (C1 ~ 6 alkyl-carbonyl group) -N- (C1 ~ 6alkoxycarbonyl) amino, unsubstituted or substituted with G 21 C1 ~ 6alkoxycarbonyloxy, unsubstituted or substituted with G 21 mono C1 ~ 6 alkoxy carbonyl group, unsubstituted or substituted with the G 22 C3 ~ 8 cycloalkyl, unsubstituted or substituted by the G 22 C3 ~ 8 cycloalkenyl group, unsubstituted or substituted by G 22 of C3 ~ 8 cycloalkyl Carbonylcarbonylaminocarbonyl, unsubstituted or substituted with G 22 C6 ~ 10 aryl, unsubstituted or substituted with G 22 C6 ~ 10 aryl C2 ~ 6 alkynyl, unsubstituted or substituted with G 22 C6 ~ 10 aryloxy, unsubstituted or substituted with the G 22 3 ~ 10 membered heterocyclic group, 13 heteroaryl, unsubstituted or substituted by the G 22 3 ~ 10 membered heteroaryl epoxy , A mercapto group, unsubstituted or substituted with G 21 of C1 ~ 6 alkylthio, unsubstituted or substituted by G of 21 C1 ~ 6 alkylsulfinyl acyl, unsubstituted or substituted with the C1 ~ 6 G 21 Alkylsulfonyl, pentafluorosulfanyl group, unsubstituted or substituted with G 22 C6 ~ 10 arylthio, unsubstituted or substituted with G 22 C6 ~ 10 arylsulfinyl, the unsubstituted or substituted by G 22 C6 ~ 10 aryl sulfonic acyl, unsubstituted or substituted with the single G 22 C6 ~ 10 aryl group, two hydroxyl groups boron (dihydroboryl group), a nitro group, a cyano Group, halo group, unsubstituted or substituted with G 21 C1-6 alkylene group, unsubstituted or substituted with G 21 C1-6 alkylene monooxy, unsubstituted or substituted with G 21- substituted C1 ~ 6 alkylene dioxy, -CR a = NR b represents the group; here, R a represents a hydrogen atom, C1 ~ 6 alkyl, unsubstituted or mono-C1 ~ substituted with G 21 6 alkylcarbonylamino, or mono-C3-8 cycloalkylcarbonylamino unsubstituted or substituted with G 22 , R b represents unsubstituted or G 21 substituted C1-6 alkoxy, unsubstituted or substituted of G 22 C3 ~ 8 cycloalkyl group, the unsubstituted or substituted by G 22 Phenoxy, unsubstituted or G 21 mono-C1 ~ 6 alkylamino group, or unsubstituted or G 21- substituted C1 ~ 6 alkylamino group; exists in the G 2 substituted group 2 In more than one case, the G 2 may be the same as or different from each other; G 21 represents a C1 to 6 alkoxy group, a C1 to 6 halogenated alkoxy group, a mono C1 to 6 alkylamino group, and a di C1 to 6 alkyl group Amine, mono (C1 ~ 6alkoxyC1 ~ 6alkylcarbonyl) amino, unsubstituted or substituted with G 211 C6 ~ 10 aryl, unsubstituted or substituted with G 211 C6 ~ 10 aryloxy group, unsubstituted or substituted with the G 211 3 ~ 10 membered heterocyclic group, unsubstituted or substituted with the G 211 3 ~ 10 membered heterocyclic group or a halogen group; the substituent on the group by the presence of two G 21 In the above cases, the G 21 may be the same as or different from each other; G 211 represents a C1 to 6 alkyl group, a C1 to 6 halogenated alkyl group, a C1 to 6 alkoxy group, a C1 to 6 halogenated alkoxy group, or a halogen group; When there are two or more groups substituted by G 211 , the G 211 may be the same as or different from each other; G 22 represents an unsubstituted or hydroxy-substituted C1 to 6 alkyl group, C1 to 6 halogenated alkyl group, C2 ~ 6 alkenyl, C2 ~ 6 halogenated alkenyl, C2 ~ 6 alkynyl, C1 ~ 6 alkoxy, C1 ~ 6 halogenated alkoxy C1 ~ 6 alkylcarbonyl, mono C1 ~ 6 alkylamino, di C1 ~ 6 alkylamino, C1 ~ 6 alkylamino carbonyl, C1 ~ 6 alkylthio, C1 ~ 6 halogenated alkylthio, C1 ~ 6 alkylsulfinyl sulfenyl, C1 ~ 6 halogenated alkylsulfinyl sulfonyl, C1 ~ 6 alkylsulfinyl sulfonyl, C1 ~ 6 halogenated alkylsulfinyl sulfonyl, C3 ~ unsubstituted or substituted with G 221 ~ 8 cycloalkyl, unsubstituted or substituted with G 221 C3 ~ 8 cycloalkyl C1 ~ 6 alkyl, unsubstituted or substituted with G 221 C6 ~ 10 aryl, unsubstituted or substituted with G 221 3- to 10-membered heterocyclyl, 3 to 10-membered heterocyclyl, unsubstituted or substituted with G 221 211 group of substituted C1 ~ 6 alkylene dioxy group, or -CR c = NOR d represents the; here, R c represents a C1 ~ 6 alkyl group, R d represents an unsubstituted or substituted by C3 ~ G 221 of 8 cycloalkyl; when there are two or more groups substituted by G 22 , the G 22 may be the same as or different from each other; G 221 represents a C1 to 6 alkyl group, a C1 to 6 halogenated alkyl group, and C1 to 6 alkoxy group, a halogenated C1 ~ 6 alkoxy group, mono C1 ~ 6 alkylamino, di-C1 ~ 6 alkyl group, C6 ~ 10 aryl group or a halogen group; the substituent on the group by the presence of G 221 2 When the above case, the G 221 to each other may be the same or different.

[2]一種農園藝用殺菌劑,其含有選自由上述[1]所記載之吡啶化合物、其N-氧化物化合物、以及其互變異構物及鹽組成之群中之至少一者作為有效成分。 [2] An agricultural and horticultural fungicide containing at least one selected from the group consisting of a pyridine compound according to the above [1], an N-oxide compound thereof, and a tautomer and a salt thereof as an active ingredient .

[3]一種有害生物防除劑,其含有選自由上述[1]所記載之吡啶化合物、其N-氧化物化合物、以及其互變異構物及鹽組成之群中之至少一者作為有效成分。 [3] A pest control agent comprising, as an active ingredient, at least one selected from the group consisting of a pyridine compound according to the above [1], an N-oxide compound thereof, and a tautomer and a salt thereof.

[4]一種殺蟲或殺蟎劑,其含有選自由上述[1]所記載之吡啶化合物、其N-氧化物化合物、以及其互變異構物及鹽組成之群中之至少一者作為有效成分。 [4] An insecticidal or acaricide containing at least one selected from the group consisting of a pyridine compound according to the above [1], an N-oxide compound thereof, and a tautomer and a salt thereof as effective ingredient.

[5]一種外部寄生蟲防除劑,其含有選自由上述[1]所記載之吡啶化合物、其N-氧化物化合物、以及其互變異構物及鹽組成之群中之至少一者作為有效成分。 [5] An external parasite controlling agent containing at least one selected from the group consisting of a pyridine compound according to the above [1], an N-oxide compound thereof, and a tautomer and a salt thereof as an active ingredient .

本發明之吡啶化合物係具有有害生物防除、殺菌、殺蟎、殺蟲等效果,不會對植物體產生藥害,對人畜魚類之毒性或對環境之影響少之新穎化合物。尤其是對麥類病害表現出優異之防除效果。本發明之吡啶化合物作為農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑之有效成分而有用。 The pyridine compound of the present invention is a novel compound that has the effects of pest control, sterilization, acaricide, insecticide, etc., does not cause phytotoxicity to plants, has little toxicity to humans, animals, fishes, and the environment. In particular, it shows excellent control effects on wheat diseases. The pyridine compound of the present invention is useful as an active ingredient of agricultural and horticultural fungicides, pest control agents, and insecticides or acaricides.

本發明之吡啶化合物係式(I)表示之吡啶化合物(以下有時記作化合物(I))、其N-氧化物化合物、化合物(I)之互變異構物或化合物(I)之鹽。 The pyridine compound of the present invention is a pyridine compound represented by formula (I) (hereinafter sometimes referred to as compound (I)), its N-oxide compound, a tautomer of compound (I), or a salt of compound (I).

首先,對有時取代式(I)中之基之基G1及G2進行說明。 First, the groups G 1 and G 2 which may substitute a group in the formula (I) will be described.

[G1] [G 1 ]

取代基G1表示羥基、C1~6烷氧基、C1~6烷氧基C1~6烷氧基、C1~6烷氧基羰基、甲醯氧基、C1~6烷基羰氧基、C1~6烷氧基羰氧基、單C1~6烷氧基羰基胺基、氰基、胺基、或鹵素基。於經G1取代之基存在2個以上之情形時,該G1互相可相同,亦可不同。 The substituent G 1 represents a hydroxyl group, a C1 to 6 alkoxy group, a C1 to 6 alkoxy group, a C1 to 6 alkoxy group, a C1 to 6 alkoxycarbonyl group, a methylamino group, a C1 to 6 alkylcarbonyloxy group, and C1 ~ 6 alkoxycarbonyloxy, mono-C1 ~ 6 alkoxycarbonylamino, cyano, amine, or halogen. When there are two or more groups substituted with G 1 , the G 1 may be the same as or different from each other.

作為C1~6烷氧基,可列舉:甲氧基、乙氧基、正丙氧基、正丁氧基、正戊氧基、正己氧基、異丙氧基、異丁氧基、二級丁氧基、三級丁氧基、異己氧基等。 Examples of C1 to 6 alkoxy include methoxy, ethoxy, n-propoxy, n-butoxy, n-pentoxy, n-hexyloxy, isopropoxy, isobutoxy, and secondary Butoxy, tertiary butoxy, isohexyloxy and the like.

作為C1~6烷氧基C1~6烷氧基,可列舉:甲氧基甲氧基、1-甲氧基乙氧基、2-甲氧基乙氧基等。 Examples of the C1 to 6 alkoxy C1 to 6 alkoxy include methoxymethoxy, 1-methoxyethoxy, and 2-methoxyethoxy.

作為C1~6烷氧基羰基,可列舉:甲氧基羰基、乙氧基羰基、正丙氧基羰基、異丙氧基羰基、三級丁氧基羰基等。 Examples of the C1 to 6 alkoxycarbonyl group include a methoxycarbonyl group, an ethoxycarbonyl group, an n-propoxycarbonyl group, an isopropoxycarbonyl group, and a tertiary butoxycarbonyl group.

作為C1~6烷基羰氧基,可列舉:乙醯氧基、丙醯氧基、丁醯氧基等。 Examples of the C1 to C6 alkylcarbonyloxy group include ethoxyl, propionyloxy, and butyloxy.

作為C1~6烷氧基羰氧基,可列舉:甲氧基羰氧基、乙氧基羰氧基、正丙氧基羰氧基、異丙氧基羰氧基、正丁氧基羰氧基、三級丁氧基羰氧基等。 Examples of C1 to 6 alkoxycarbonyloxy include methoxycarbonyloxy, ethoxycarbonyloxy, n-propoxycarbonyloxy, isopropoxycarbonyloxy, and n-butoxycarbonyloxy. And tertiary butoxycarbonyloxy.

單C1~6烷氧基羰基胺基係於胺基上單取代有上文所述之C1~6烷氧基羰基者。作為C1~6烷氧基羰基胺基,可列舉:甲氧基羰基胺基、乙氧基羰基胺基、正丙氧基羰基胺基、異丙氧基羰基胺基、正丁氧基羰基胺基、三級丁氧基羰基胺基等。 The mono-C1 ~ 6 alkoxycarbonylamino group is a mono-substituted C1 ~ 6 alkoxycarbonyl group on the amine group. Examples of the C1 to 6 alkoxycarbonylamino group include a methoxycarbonylamino group, an ethoxycarbonylamino group, an n-propoxycarbonylamino group, an isopropoxycarbonylamino group, and an n-butoxycarbonylamine group. And tertiary butoxycarbonylamino groups.

作為鹵素基,可列舉:氟基、氯基、溴基、碘基。 Examples of the halogen group include a fluoro group, a chloro group, a bromo group, and an iodo group.

作為G1,較佳為羥基、C1~6烷氧基或鹵素基。 G 1 is preferably a hydroxyl group, a C1 to 6 alkoxy group, or a halogen group.

[G2] [G 2 ]

G2表示未經取代或經G21取代之C1~8烷基、未經取代或經G21取代之C2~6烯基、未經取代或經G21取代之C2~6炔基、羥基、未經取代或經G21取代之C1~6烷氧基、甲醯基、未經取代或經G21取代之C1~6烷基羰基、未經取代或經G21取代之C1~6烷氧基羰基、甲醯氧基、未經取代或經G21取代之C1~6烷基羰氧基、甲醯基胺基、未經取代或經G21取代之單C1~6烷基羰基胺基、未經取代或經G21取代之N-(C1~6烷基羰基)-N-(C1~6烷基)胺基、未經取代或經G21取代之N-(C1~6烷基羰基)-N-(C1~6烷氧基羰基)胺基、未經取代或經G21取代之C1~6烷氧基羰氧基、未經取代或經G21取代之單C1~6烷氧基羰基胺基、未經取代或經G22取代之C3~8環烷基、未經取代或經G22取代之C3~8環烯基、未經取代或經G22取代之C3~8環烷 基羰基胺基羰基、未經取代或經G22取代之C6~10芳基、未經取代或經G22取代之C6~10芳基C2~6炔基、未經取代或經G22取代之C6~10芳氧基、未經取代或經G22取代之3~10員雜環基、13員雜芳基、未經取代或經G22取代之3~10員雜環氧基、巰基、未經取代或經G21取代之C1~6烷硫基、未經取代或經G21取代之C1~6烷基亞磺醯基、未經取代或經G21取代之C1~6烷基磺醯基、五氟硫基、未經取代或經G22取代之C6~10芳硫基、未經取代或經G22取代之C6~10芳基亞磺醯基、未經取代或經G22取代之C6~10芳基磺醯基、未經取代或經G22取代之單C6~10芳基胺基、二氫氧硼基、硝基、氰基、鹵素基、未經取代或經G21取代之C1~6伸烷基、未經取代或經G21取代之C1~6伸烷基單氧基、未經取代或經G21取代之C1~6伸烷基二氧基、-CRa=NRb表示之基。 G 2 represents an unsubstituted or G 21 substituted C1-8 alkyl group, an unsubstituted or G 21 substituted C2-6 alkenyl group, an unsubstituted or G 21 substituted C2-6 alkynyl group, a hydroxyl group, Unsubstituted or G 21 substituted C1 ~ 6 alkoxy, formamyl, unsubstituted or G 21 substituted C1 ~ 6 alkylcarbonyl, unsubstituted or G 21 substituted C1 ~ 6 alkoxy Carbonyl, methylamino, unsubstituted or G 21 substituted C1 ~ 6 alkylcarbonyloxy, methylamino, unsubstituted or G 21 substituted mono C1 ~ 6 alkylcarbonylamino , unsubstituted or substituted with the G 21 N- (C1 ~ 6 alkyl-carbonyl) -N- (C1 ~ 6 alkyl) amino, unsubstituted or substituted with the N- G 21 (C1 ~ 6 alkyl (Carbonyl) -N- (C1 ~ 6alkoxycarbonyl) amino, unsubstituted or substituted with G 21 C1 ~ 6alkoxycarbonyloxy, unsubstituted or substituted with G 21 mono C1 ~ 6 alkyl Oxycarbonylamino, unsubstituted or substituted with G 22 C3 ~ 8 cycloalkyl, unsubstituted or substituted with G 22 C3 ~ 8 cycloalkenyl, unsubstituted or substituted with G 22 C3 ~ 8 cycloalkylcarbonyl aminocarbonyl, unsubstituted or substituted by G 22 of the C6 ~ 10 aryl group, unsubstituted or substituted by G 22 C6 ~ 10 aryl group of C2 ~ 6 alkynyl group, without Or substituted on behalf of G 22 C6 ~ 10 aryloxy, unsubstituted or substituted with the G 22 3 ~ 10 membered heterocyclic group, 13 heteroaryl, unsubstituted or substituted by the G 22 3 ~ 10 membered Heterocyclyloxy, mercapto, unsubstituted or substituted with C 21 ~ 6 alkylthio, unsubstituted or substituted with G 21 alkyl sulfinyl sulfenyl, unsubstituted or substituted with G 21 C1 ~ 6 alkylsulfonyl, pentafluorothio, unsubstituted or substituted with G 22 C6 ~ 10 arylthio, unsubstituted or substituted with G 22 C6 ~ 10 arylsulfinyl, the unsubstituted or substituted by G 22 C6 ~ 10 aryl sulfonic acyl, unsubstituted or substituted with the single G 22 C6 ~ 10 aryl group, di boron hydroxyl group, a nitro group, a cyano group, a halogen group , Unsubstituted or substituted with G 21 C1 ~ 6 alkylene, unsubstituted or substituted with G 21 C1 ~ 6 alkyl monooxy, unsubstituted or substituted with G 21 C1 ~ 6 alkylene Dioxy, -CR a = NR b .

此處,Ra表示氫原子、C1~6烷基、未經取代或經G21取代之單C1~6烷基羰基胺基、或者未經取代或經G22取代之單C3~8環烷基羰基胺基,Rb表示未經取代或經G21取代之C1~6烷氧基、未經取代或經G22取代之C3~8環烷氧基、未經取代或經G22取代之苯氧基、未經取代或經G21取代之單C1~6烷基胺基、或者未經取代或經G21取代之二C1~6烷基胺基。於經G2取代之基存在2個以上之情形時,該G2互相可相同,亦可不同。 Here, R a represents a hydrogen atom, a C1 to 6 alkyl group, a mono-C1 to 6 alkylcarbonylamino group which is unsubstituted or substituted with G 21 , or a mono C3 to 8 cycloalkane group which is unsubstituted or substituted with G 22 Carbonylamino, R b represents an unsubstituted or G 21 substituted C1-6 alkoxy group, an unsubstituted or G 22 substituted C3-8 cycloalkoxy group, an unsubstituted or G 22 substituted phenoxy, unsubstituted or substituted with G 21 of the single-C1 ~ 6 alkyl group, or an unsubstituted or substituted bis G 21 C1 ~ 6 alkyl group. When there are two or more groups substituted with G 2 , the G 2 may be the same as or different from each other.

取代基G2中之C1~6烷氧基、C1~6烷氧基羰基、C1~6烷基羰氧基、C1~6烷氧基羰氧基、單C1~6烷氧基羰基胺基、及鹵素基係如已述者。 C1 ~ 6 alkoxy, C1 ~ 6 alkoxycarbonyl, C1 ~ 6 alkylcarbonyloxy, C1 ~ 6 alkoxycarbonyloxy, mono C1 ~ 6 alkoxycarbonylamino in substituent G 2 , And halogen groups are as described.

C1~8烷基可為直鏈,若碳數為3以上,則亦可為支鏈。作為C1~6烷基,可列舉:甲基、乙基、正丙基、異丙基、正丁基、二級丁 基、異丁基、三級丁基、正戊基、正己基、異戊基、新戊基、2-甲基丁基、2,2-二甲基丙基、異己基、正庚基、正辛基等。 The C1-8 alkyl group may be a straight chain, and if the carbon number is 3 or more, it may be branched. Examples of the C1-6 alkyl group include methyl, ethyl, n-propyl, isopropyl, n-butyl, secondary butyl, isobutyl, tertiary butyl, n-pentyl, n-hexyl, and iso Amyl, neopentyl, 2-methylbutyl, 2,2-dimethylpropyl, isohexyl, n-heptyl, n-octyl and the like.

作為C2~6烯基,可列舉:乙烯基、1-丙烯基、2-丙烯基(烯丙基)、1-丁烯基、2-丁烯基、3-丁烯基、1-甲基乙烯基(異丙烯基)、1-甲基-2-丙烯基、2-甲基-2-丙烯基、1-戊烯基、2-戊烯基、3-戊烯基、4-戊烯基、1-甲基-2-丁烯基、2-甲基-2-丁烯基、1-己烯基、2-己烯基、3-己烯基、4-己烯基、5-己烯基等。 Examples of C2-6 alkenyl include vinyl, 1-propenyl, 2-propenyl (allyl), 1-butenyl, 2-butenyl, 3-butenyl, and 1-methyl Vinyl (isopropenyl), 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentene Base, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5- Hexenyl and the like.

作為C2~6炔基,可列舉:乙炔基、1-丙炔基、2-丙炔基、1-丁炔基、2-丁炔基、3-丁炔基、1-甲基-2-丙炔基、2-甲基-3-丁炔基、1-戊炔基、2-戊炔基、3-戊炔基、4-戊炔基、1-甲基-2-丁炔基、2-甲基-3-戊炔基、1-己炔基、1,1-二甲基-2-丁炔基等。 Examples of C2-6 alkynyl include ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, and 1-methyl-2- Propynyl, 2-methyl-3-butynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 2-methyl-3-pentynyl, 1-hexynyl, 1,1-dimethyl-2-butynyl, and the like.

C1~6烷基羰基係於羰基上鍵結有上文所述之C1~6烷基者。作為C1~6烷基羰基,可列舉:乙醯基、丙醯基、丁醯基、異丁醯基、三甲基乙醯基等。 The C1 ~ 6 alkylcarbonyl group is a group in which the C1 ~ 6 alkyl group described above is bonded to the carbonyl group. Examples of the C1 to C6 alkylcarbonyl group include an ethylfluorenyl group, a propylfluorenyl group, a butylfluorenyl group, an isobutylfluorenyl group, and a trimethylethylfluorenyl group.

單C1~6烷基羰基胺基係於胺基上單取代有上文所述之C1~6烷基羰基者。作為單C1~6烷基羰基胺基,可列舉:乙醯基胺基、丙醯基胺基、丁醯基胺基、異丙基羰基胺基、2,2-二甲基丙基羰基胺基等。 The mono-C1-6 alkylcarbonylamino group is a mono-substituted C1-6 alkylcarbonyl group on the amine group. Examples of the mono-C1-6 alkylcarbonylamino group include an ethylamino group, a propylamino group, a butylamino group, an isopropylcarbonylamino group, a 2,2-dimethylpropylcarbonylamino group, and the like. .

N-(C1~6烷基羰基)-N-(C1~6烷基)胺基係於胺基上取代有上文所述之C1~6烷基與C1~6烷基羰基者。作為N-(C1~6烷基羰基)-N-(C1~6烷基)胺基,可列舉N-(2,2-二甲基丙基羰基)-N-甲基胺基等。 N- (C1 ~ 6alkylcarbonyl) -N- (C1 ~ 6alkyl) amino group is substituted on the amine group with the above-mentioned C1 ~ 6alkyl group and C1 ~ 6alkylcarbonyl group. Examples of the N- (C1-6 alkylcarbonyl) -N- (C1-6 alkyl) amino group include N- (2,2-dimethylpropylcarbonyl) -N-methylamino group.

N-(C1~6烷基羰基)-N-(C1~6烷氧基羰基)胺基係於胺基上取代有上文所述之C1~6烷氧基羰基與C1~6烷基羰基者。作為N-(C1~6 烷基羰基)-N-(C1~6烷氧基羰基)胺基,可列舉N-乙醯基-N-甲氧基羰基胺基等。 N- (C1 ~ 6 alkylcarbonyl) -N- (C1 ~ 6 alkoxycarbonyl) amino group is substituted on the amine group with the above-mentioned C1 ~ 6 alkoxycarbonyl group and C1 ~ 6 alkylcarbonyl group By. Examples of the N- (C1 to 6 alkylcarbonyl) -N- (C1 to 6 alkoxycarbonyl) amino group include N-ethylfluorenyl-N-methoxycarbonylamino group.

作為C3~8環烷基,可列舉:環丙基、環丁基、環戊基、環己基、環庚基、2-金剛烷基等。 Examples of C3 to 8 cycloalkyl include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, 2-adamantyl, and the like.

作為C3~8環烯基,可列舉:環丙烯基、環丁烯基、環戊烯基、環己烯基、環庚烯基等。 Examples of the C3 to 8 cycloalkenyl include cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, and the like.

作為C3~8環烷基羰基胺基羰基,可列舉以下之式所表示之基等。*表示鍵結位置。 Examples of the C3-8 cycloalkylcarbonylaminocarbonyl group include a group represented by the following formula. * indicates the bonding position.

C6~10芳基可為單環及多環之任一者。若多環芳基中至少一個環為芳香環,則其餘環可為飽和脂環、不飽和脂環或芳香環之任一者。作為C6~10芳基,可列舉:苯基、萘基、薁基、茚基、二氫茚基、四氫萘基等。 The C6-10 aryl group may be any of a monocyclic ring and a polycyclic ring. If at least one ring in the polycyclic aryl group is an aromatic ring, the remaining rings may be any of a saturated alicyclic ring, an unsaturated alicyclic ring, or an aromatic ring. Examples of the C6-10 aryl group include a phenyl group, a naphthyl group, a fluorenyl group, an indenyl group, a dihydroindenyl group, and a tetrahydronaphthyl group.

C6~10芳基C2~6炔基係於上文所述之C2~6炔基上取代有上文所述之C6~10芳基者。作為C6~10芳基C2~6炔基,可列舉苯基乙炔基等。 C6 ~ 10 aryl C2 ~ 6 alkynyl is substituted on the C2 ~ 6 alkynyl group described above with the C6 ~ 10 aryl group described above. Examples of the C6 to 10 aryl C2 to 6 alkynyl group include phenylethynyl and the like.

C6~10芳氧基係於羥基上取代有上文所述之C6~10芳基者。作為C6~10芳氧基,可列舉苯氧基、萘氧基等。 The C6 ~ 10 aryloxy group is substituted on the hydroxyl group with the C6 ~ 10 aryl group described above. Examples of the C6 to 10 aryloxy group include a phenoxy group and a naphthyloxy group.

3~10員雜環基含有選自由氮原子、氧原子及硫原子組成之 群中之1~4個雜原子作為環之構成原子之環狀之基。雜環基可為單環及多環之任一者。若多環雜環基之至少一個環為雜環基,則其餘環可為飽和脂環、不飽和脂環或芳香環之任一者。作為3~10員雜環基,可列舉:3~10員飽和雜環基、5~10員雜芳基、5~6員部分不飽和雜環基等。 The 3- to 10-membered heterocyclic group contains a cyclic group having 1 to 4 heteroatoms selected from the group consisting of a nitrogen atom, an oxygen atom, and a sulfur atom as the constituent atoms of the ring. The heterocyclic group may be any of a monocyclic ring and a polycyclic ring. If at least one ring of the polycyclic heterocyclic group is a heterocyclic group, the remaining rings may be any of a saturated alicyclic ring, an unsaturated alicyclic ring, or an aromatic ring. Examples of the 3 to 10-membered heterocyclic group include a 3 to 10-membered saturated heterocyclic group, a 5 to 10-membered heteroaryl group, and a 5 to 6-membered partially unsaturated heterocyclic group.

作為3~10員飽和雜環基,可列舉:氮丙啶基、氧雜環丙基(oxiranyl group)、氮雜環丁基(azetidinyl group)、氧雜環丁基(oxetanyl group)、吡咯啶基、四氫呋喃基、四氫噻唑基、哌啶基、哌基、啉基、四氫吡喃基、二氧雜環戊基(dioxolanyl group)、二氧雜環己基(dioxanyl group)、異唑啶基(isoxazolidinyl group)、3-氧雜異唑啶基、4,4,5,5-四甲基-1,3,2-二氧硼戊環基(4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl group)等。 Examples of the 3 to 10-membered saturated heterocyclic group include aziridinyl, oxiranyl group, azetidinyl group, oxetanyl group, and pyrrolidine Tetrahydrofuranyl, tetrahydrothiazolyl, piperidinyl, piperidinyl base, Phosphono, tetrahydropyranyl, dioxolanyl group, dioxanyl group, iso Isoxazolidinyl group, 3-oxa Amidazinyl, 4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl (4,4,5,5-tetramethyl-1,3,2-dioxaborolanyl group) and the like.

作為5員雜芳基,可列舉:吡咯基、呋喃基、噻吩基、咪唑基、吡唑基、唑基、異唑基、噻唑基、異噻唑基、三唑基、二唑基、噻二唑基、四唑基等。 Examples of the 5-membered heteroaryl group include pyrrolyl, furyl, thienyl, imidazolyl, pyrazolyl, Oxazolyl, iso Oxazolyl, thiazolyl, isothiazolyl, triazolyl, Diazolyl, thiadiazolyl, tetrazolyl, and the like.

作為6員雜芳基,可列舉:吡啶基、吡基、嘧啶基、嗒基、三基等。 Examples of the 6-membered heteroaryl group include pyridyl, pyridine Base, pyrimidinyl, Base, three Base etc.

作為5~6員部分不飽和雜環基,可列舉二氫異唑基等。 Examples of 5- to 6-membered unsaturated heterocyclic groups include dihydroiso Azole and others.

作為9員雜芳基,可列舉:吲哚基、異吲哚基、苯并呋喃基、二氫苯并呋喃基、吲唑基、苯并唑基、苯并異唑基、苯并噻唑基、苯并異噻唑基、吡啶基吡唑基、三唑并吡啶基等。 Examples of the 9-membered heteroaryl include indolyl, isoindolyl, benzofuranyl, dihydrobenzofuranyl, indazolyl, and benzo. Oxazolyl An oxazolyl group, a benzothiazolyl group, a benzoisothiazolyl group, a pyridylpyrazolyl group, a triazolopyridyl group, and the like.

作為9員部分不飽和雜環基,可列舉:吲哚啉基、異吲哚啉基、1,3-二側氧基異吲哚啉基等。 Examples of the 9-membered partially unsaturated heterocyclic group include an indololinyl group, an isoindolinyl group, and a 1,3-dioxoisoindolinyl group.

作為10員雜芳基,可列舉:喹啉基、異喹啉基、啉基、呔基、 喹唑啉基、喹啉基等。 Examples of the 10-membered heteroaryl group include quinolinyl, isoquinolinyl, Phenyl Quinolyl Phenyl and so on.

作為13員雜芳基,可列舉:二苯并[b,d]呋喃基、二苯并[b,d]噻吩基等。 Examples of the 13-membered heteroaryl group include dibenzo [b, d] furanyl, dibenzo [b, d] thienyl, and the like.

3~10員雜環氧基係於羥基上取代有上文所述之3~10員雜環基者。作為3~10員雜環氧基,可列舉吡唑氧基、吡啶氧基等。3~10員雜環氧基較佳為5~6員雜環氧基。 The 3- to 10-membered heterocyclooxy group is substituted on the hydroxyl group with the 3- to 10-membered heterocyclic group described above. Examples of the 3- to 10-membered heterocyclic oxy group include pyrazolyloxy and pyridyloxy. The 3 to 10-membered heterocyclic oxy group is preferably a 5 to 6-membered heterocyclic oxy group.

C1~6烷硫基係於SH基上取代有上文所述之C1~6烷基者。作為C1~6烷硫基,可列舉:甲硫基、乙硫基、正丙硫基、正丁硫基、正戊硫基、正己硫基、異丙硫基、異丁硫基等。 The C1 ~ 6 alkylthio group is substituted on the SH group with the C1 ~ 6 alkyl group described above. Examples of the C1-6 alkylthio group include methylthio, ethylthio, n-propylthio, n-butylthio, n-pentylthio, n-hexylthio, isopropylthio, and isobutylthio.

C1~6烷基亞磺醯基係於亞磺醯基上取代有上文所述之C1~6烷基者。作為C1~6烷基亞磺醯基,可列舉:甲基亞磺醯基、乙基亞磺醯基、三級丁基亞磺醯基等。 The C1-6 alkylsulfinyl sulfenyl group is substituted on the sulfinyl sulfinyl group with the C1-6 alkyl group described above. Examples of the C1-6 alkylsulfinylsulfenyl group include a methylsulfinylsulfonyl group, an ethylsulfinylsulfinyl group, and a tertiary butylsulfinylsulfinyl group.

C1~6烷基磺醯基係於磺醯基上取代有上文所述之C1~6烷基者。作為C1~6烷基磺醯基,可列舉:甲基磺醯基、乙基磺醯基、三級丁基磺醯基等。 The C1 ~ 6 alkylsulfonyl group is substituted on the sulfonyl group with the C1 ~ 6 alkyl group described above. Examples of the C1-6 alkylsulfonyl group include a methylsulfonyl group, an ethylsulfonyl group, and a tertiary butylsulfonyl group.

C6~10芳硫基係於SH基上取代有上文所述之C6~10芳基者。作為C6~10芳硫基,可列舉:苯硫基、萘硫基等。 The C6-10 arylthio group is substituted on the SH group with the C6-10 aryl group described above. Examples of the C6 to 10 arylthio group include a phenylthio group and a naphthylthio group.

C6~10芳基亞磺醯基係於亞磺醯基上取代有上文所述之C6~10芳基者。作為C6~10芳基亞磺醯基,可列舉:苯基亞磺醯基、萘基亞磺醯基等。 C6 ~ 10 arylsulfinyl is substituted on the sulfinyl with the C6 ~ 10 aryl described above. Examples of the C6 to 10 arylsulfinyl sulfenyl group include a phenylsulfinyl sulfinyl group, a naphthylsulfinyl sulfinyl group, and the like.

C6~10芳基磺醯基係於磺醯基上取代有上文所述之C6~10芳基者。作為C6~10芳基磺醯基,可列舉:苯基磺醯基、萘基磺醯基等。 The C6-10 arylsulfonyl group is substituted on the sulfonyl group with the C6-10 aryl group described above. Examples of the C6 to 10 arylsulfonyl group include a phenylsulfonyl group and a naphthylsulfonyl group.

C6~10芳基胺基係於胺基上取代有上文所述之C6~10芳基者。作為C6~10芳基胺基,可列舉苯基胺基等。 The C6 ~ 10 arylamino group is substituted on the amine group with the C6 ~ 10 aryl group described above. Examples of the C6 to 10 arylamino group include a phenylamino group and the like.

作為C1~6伸烷基,為脫去C1~6烷烴中之2個氫原子而成之二價基。作為C1~6伸烷基,可列舉:亞甲基、伸乙基(二亞甲基)、三亞甲基、四亞甲基、丙烷-1,2-二基(即伸丙基)等。作為經作為G2之C1~6伸烷基取代之C6~10芳基,可列舉:2,3-二氫-1H-茚基、5,6,7,8-四萘基等。 The C1 ~ 6 alkylene group is a divalent group obtained by removing two hydrogen atoms in a C1 ~ 6 alkane. Examples of the C1 to 6 alkylene group include a methylene group, an ethylene group (dimethylene group), a trimethylene group, a tetramethylene group, and a propane-1,2-diyl group (that is, a propylene group). Examples of the C6 to 10 aryl group substituted with a C1 to 6 alkylene group as G 2 include 2,3-dihydro-1H-indenyl, 5,6,7,8-tetranaphthyl and the like.

作為C1~6伸烷基單氧基,為C1~6烷烴中之1個氫原子經氧基取代而成之二價基。作為C1~6伸烷基單氧基,可列舉:亞甲基單氧基(-CH2O-)、伸乙基單氧基(-CH2CH2O-)、三亞甲基單氧基(-CH2CH2CH2O-)等。作為經作為G2之C1~6伸烷基單氧基取代之C6~10芳基,可列舉:2,3-二氫苯并呋喃基、基等。 The C1 ~ 6 alkylene monooxy group is a divalent group in which one hydrogen atom in a C1 ~ 6 alkane is substituted with an oxy group. Examples of the C1 to 6 alkylene monooxy group include a methylene monooxy group (-CH 2 O-), an ethylene monooxy group (-CH 2 CH 2 O-), and a trimethylene monooxy group. (-CH 2 CH 2 CH 2 O-) and the like. Examples of the C6-10 aryl group substituted with a C1-6 alkylene monooxy group as G 2 include 2,3-dihydrobenzofuranyl, Base etc.

C1~6伸烷基二氧基係C1~6烷烴中之2個氫原子經氧基取代而成之二價基。作為C1~6伸烷基二氧基,可列舉:亞甲基二氧基(-OCH2O-)、伸乙基二氧基(-OCH2CH2O-)、三亞甲基二氧基等。作為經作為G2之C1~6伸烷基二氧基取代之C6~10芳基,可列舉:2,3-二氫-苯并[1,4]二烴氧基(2,3-dihydro-benzo[1,4]dioxyl group)、苯并[1,3]二氧雜環戊烯基(benzo[1,3]dioxolyl group)等。 C1 ~ 6 alkylene dioxy is a divalent group in which two hydrogen atoms in a C1 ~ 6 alkane are substituted with an oxy group. Examples of the C1 to 6 alkylene dioxy group include a methylene dioxy group (-OCH 2 O-), an ethylene dioxy group (-OCH 2 CH 2 O-), and a trimethylene dioxy group. Wait. Examples of the C6-10 aryl group substituted with a C1-6 alkylene dioxy group as G 2 include 2,3-dihydro-benzo [1,4] dihydrocarbyloxy (2,3-dihydro -benzo [1,4] dioxyl group), benzo [1,3] dioxolyl group, and the like.

式:-CRa=NRb表示之基中之Ra中之C1~6烷基、單C1~6烷基羰基胺基係如已述者。 The formula: -CR a = NR b , the C1 ~ 6 alkyl group and mono C1 ~ 6 alkylcarbonylamino group in R a are as described above.

作為Ra中之單C3~8環烷基羰基胺基,可列舉:環丙基羰基胺基、環丁基羰基胺基、環戊基羰基胺基、環己基羰基胺基等。 Examples of the mono-C3-8 cycloalkylcarbonylamino group in R a include a cyclopropylcarbonylamino group, a cyclobutylcarbonylamino group, a cyclopentylcarbonylamino group, a cyclohexylcarbonylamino group, and the like.

式:-CRa=NRb表示之基中之Rb中之C1~6烷氧基、C3~8環烷氧基係如已述者。 Formula: -CR a = NR b The C1 ~ 6 alkoxy group and C3 ~ 8 cycloalkoxy group in R b in the group represented by those are as already described.

作為Rb中之單C1~6烷基胺基,可列舉:甲基胺基、乙基胺基等。 Examples of the mono-C 1 to 6 alkylamino group in R b include a methylamino group and an ethylamino group.

作為Rb中之二C1~6烷基胺基,可列舉:二甲胺基、二乙胺基等。 Examples of the C1-C6 alkylamino group in Rb include a dimethylamino group and a diethylamino group.

[G21] [G 21 ]

G21表示C1~6烷氧基、C1~6鹵化烷氧基、單C1~6烷基胺基、二C1~6烷基胺基、單(C1~6烷氧基C1~6烷基羰基)胺基、未經取代或經G211取代之C6~10芳基、未經取代或經G211取代之C6~10芳氧基、未經取代或經G211取代之3~10員雜環基、未經取代或經G211取代之3~10員雜環氧基或鹵素基。於經G21取代之基存在2個以上之情形時,該G21互相可相同,亦可不同。 G 21 represents C1 to 6 alkoxy, C1 to 6 halogenated alkoxy, mono C1 to 6 alkylamino, di C1 to 6 alkylamino, mono (C1 to 6 alkoxyC1 to 6 alkylcarbonyl ) Amine, unsubstituted or substituted with G 211 C6 ~ 10 aryl, unsubstituted or substituted with G 211 C6 ~ 10 aryloxy, unsubstituted or substituted with G 211 3 to 10 membered heterocyclic ring 3 to 10 membered heterocyclic oxy or halo, unsubstituted or substituted with G 211 . When there are two or more groups substituted with G 21 , the G 21 may be the same as or different from each other.

取代基G21中之C1~6烷氧基、C6~10芳基、單C1~6烷基胺基、二C1~6烷基胺基、C6~10芳氧基、3~10員雜環基、3~10員雜環氧基、及鹵素基係如已述者。 C1 ~ 6 alkoxy, C6 ~ 10 aryl, mono C1 ~ 6 alkylamino, di C1 ~ 6 alkylamino, C6 ~ 10 aryloxy, 3 ~ 10 member heterocyclic ring in substituent G 21 The radicals, 3 to 10-membered heterocyclooxy, and halogen radicals are as described above.

C1~6鹵化烷氧基係於已述之C1~6烷氧基上取代有鹵素基者。 The C1 ~ 6 halogenated alkoxy group is a halogen group substituted on the C1 ~ 6 alkoxy group described above.

作為C1~6鹵化烷氧基,可列舉:氯甲氧基、二氯甲氧基、二氟甲氧基、三氯甲氧基、三氟甲氧基、1-氟乙氧基、1,1-二氟乙氧基、2,2,2-三氟乙氧基、1,1,2,2-四氟乙氧基、五氟乙氧基、2,2,3,4,4,4-六氟-丁氧基、1-溴-1,1,2,2-四氟乙氧基等。 Examples of C1 to 6 halogenated alkoxy groups include chloromethoxy, dichloromethoxy, difluoromethoxy, trichloromethoxy, trifluoromethoxy, 1-fluoroethoxy, 1, 1-difluoroethoxy, 2,2,2-trifluoroethoxy, 1,1,2,2-tetrafluoroethoxy, pentafluoroethoxy, 2,2,3,4,4, 4-hexafluoro-butoxy, 1-bromo-1,1,2,2-tetrafluoroethoxy and the like.

作為單(C1~6烷氧基C1~6烷基羰基)胺基,可列舉:甲氧基甲基羰基胺基、乙氧基甲基羰基胺基、2-甲氧基乙基羰基胺基、2-乙氧基乙基羰基胺基等。 Examples of the mono (C1 ~ 6alkoxyC1 ~ 6alkylcarbonyl) amino group include a methoxymethylcarbonylamino group, an ethoxymethylcarbonylamino group, and a 2-methoxyethylcarbonylamino group , 2-ethoxyethylcarbonylamino and the like.

作為G21,較佳為鹵素基。 G 21 is preferably a halogen group.

[G211] [G 211 ]

G211表示C1~6烷基、C1~6鹵化烷基、C1~6烷氧基、C1~6鹵化烷氧基或鹵素基。於經G211取代之基存在2個以上之情形時,該G211互相可相同,亦可不同。 G 211 represents a C1 to 6 alkyl group, a C1 to 6 halogenated alkyl group, a C1 to 6 alkoxy group, a C1 to 6 halogenated alkoxy group, or a halogen group. When two or more groups substituted by G 211 exist, the G 211 may be the same as or different from each other.

G211中之C1~6烷基、C1~6烷氧基、C1~6鹵化烷氧基、及鹵素基係如已述者。 The C1 ~ 6 alkyl group, C1 ~ 6 alkoxy group, C1 ~ 6 halogenated alkoxy group, and halogen group in G 211 are as described above.

C1~6鹵化烷基係於已述之C1~6烷基上取代有鹵素基者。作為C1~6鹵化烷基,可列舉:氟甲基、氯甲基、溴甲基、二氟甲基、二氯甲基、二溴甲基、三氟甲基、三氯甲基、三溴甲基、1-氯乙基、2,2,2-三氟乙基、2,2,2-三氯乙基、五氟乙基、4-氟丁基、4-氯丁基、3,3,3-三氟丙基、2,2,2-三氟-1-三氟甲基乙基、全氟己基、全氯己基、2,4,6-三氯己基等。 The C1 ~ 6 haloalkyl group is a halogen group substituted on the C1 ~ 6 alkyl group described above. Examples of the C1 to 6 halogenated alkyl group include fluoromethyl, chloromethyl, bromomethyl, difluoromethyl, dichloromethyl, dibromomethyl, trifluoromethyl, trichloromethyl, and tribromo. Methyl, 1-chloroethyl, 2,2,2-trifluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 4-fluorobutyl, 4-chlorobutyl, 3, 3,3-trifluoropropyl, 2,2,2-trifluoro-1-trifluoromethylethyl, perfluorohexyl, perchlorohexyl, 2,4,6-trichlorohexyl and the like.

作為G211,較佳為C1~6烷基,尤佳為甲基。 G 211 is preferably a C1 to 6 alkyl group, and particularly preferably a methyl group.

[G22] [G 22 ]

G22表示未經取代或經羥基取代之C1~6烷基、C1~6鹵化烷基、C2~6烯基、C2~6鹵化烯基、C2~6炔基、C1~6烷氧基、C1~6鹵化烷氧基、C1~6烷基羰基、單C1~6烷基胺基、二C1~6烷基胺基、C1~6烷基胺基羰基、C1~6烷硫基、C1~6鹵化烷硫基、C1~6烷基亞磺醯基、C1~6鹵化烷基亞磺醯基、C1~6烷基磺醯基、C1~6鹵化烷基磺醯基、未經取代或 經G221取代之C3~8環烷基、未經取代或經G221取代之C3~8環烷基C1~6烷基、未經取代或經G221取代之C6~10芳基、未經取代或經G221取代之3~10員雜環基、未經取代或經G221取代之3~10員雜環基羰基、五氟硫基、硝基、氰基、鹵素基、側氧基、未經取代或經G211取代之C1~6伸烷基二氧基、或-CRc=NORd表示之基。此處,Rc表示C1~6烷基,Rd表示未經取代或經G221取代之C3~8環烷基。於經G22取代之基存在2個以上之情形時,該G22互相可相同,亦可不同。 G 22 represents unsubstituted or hydroxy-substituted C1 ~ 6 alkyl, C1 ~ 6 halogenated alkyl, C2 ~ 6 alkenyl, C2 ~ 6 halogenated alkenyl, C2 ~ 6 alkynyl, C1 ~ 6 alkoxy, C1 ~ 6 halogenated alkoxy, C1 ~ 6 alkylcarbonyl, mono C1 ~ 6 alkylamino, di C1 ~ 6 alkylamino, C1 ~ 6 alkylamino carbonyl, C1 ~ 6 alkylthio, C1 ~ 6 haloalkylthio, C1 ~ 6 alkylsulfinamilide, C1 ~ 6 haloalkylsulfinamido, C1 ~ 6 alkylsulfofluorenyl, C1 ~ 6 haloalkylsulfinyl, unsubstituted or substituted of G 221 C3 ~ 8 cycloalkyl, unsubstituted or substituted by the G 221 C3 ~ 8 cycloalkyl, C1 ~ 6 alkyl, the unsubstituted or substituted by G 221 C6 ~ 10 aryl group, an 3- to 10-membered heterocyclyl substituted or substituted with G 221 , 3- to 10-membered heterocyclyl substituted or unsubstituted or substituted with G 221 , pentafluorothio, nitro, cyano, halogen, pendant oxygen Group, C1-C6 alkylenedioxy group which is unsubstituted or substituted with G 211 , or a group represented by -CR c = NOR d . Here, R c represents a C1 to 6 alkyl group, and R d represents a C3 to 8 cycloalkyl group which is unsubstituted or substituted with G 221 . When there are two or more groups substituted with G 22 , the G 22 may be the same as or different from each other.

取代基G22中之C1~6烷基、C1~6鹵化烷基、C2~6烯基、C2~6炔基、C1~6烷氧基、C1~6鹵化烷氧基、C1~6烷基羰基、單C1~6烷基胺基、二C1~6烷基胺基、C1~6烷硫基、C1~6烷基亞磺醯基、C1~6烷基磺醯基、C3~8環烷基、C6~10芳基、3~10員雜環基及鹵素基、C1~6伸烷基二氧基係如已述者。 C1 ~ 6 alkyl, C1 ~ 6 halogenated alkyl, C2 ~ 6 alkenyl, C2 ~ 6 alkynyl, C1 ~ 6 alkoxy, C1 ~ 6 halogenated alkoxy, C1 ~ 6 alkyl in substituent G 22 Carbonyl group, mono-C1 ~ 6 alkylamino group, di-C1 ~ 6 alkylamino group, C1 ~ 6 alkylthio group, C1 ~ 6 alkylsulfinamilide group, C1 ~ 6 alkylsulfonyl group, C3 ~ 8 The cycloalkyl group, C6-10 aryl group, 3-10 member heterocyclic group and halogen group, and C1-6 alkylene dioxy group are as described above.

C2~6鹵化烯基係於已述之C1~6烯基上取代有鹵素基者。作為C2~6鹵化烯基,可列舉:2-氯乙烯基、2-溴乙烯基、2-碘乙烯基、1-氟-2-碘乙烯基、2-氯-1-丙烯基、2-氟-1-丁烯基等。 The C2 ~ 6 halogenated alkenyl group is a halogen group substituted on the C1 ~ 6 alkenyl group already described. Examples of C2 to 6 halogenated alkenyl include 2-chlorovinyl, 2-bromovinyl, 2-iodovinyl, 1-fluoro-2-iodovinyl, 2-chloro-1-propenyl, 2- Fluoro-1-butenyl and the like.

作為C3~8環烷基C1~6烷基,可列舉:環丙基甲基、2-環丙基乙基、環戊基甲基、2-環己基乙基、2-環辛基乙基等。 Examples of the C3-8 cycloalkyl C1-6 alkyl include cyclopropylmethyl, 2-cyclopropylethyl, cyclopentylmethyl, 2-cyclohexylethyl, and 2-cyclooctylethyl Wait.

作為C1~6烷基胺基羰基,可列舉:甲基胺基羰基、二甲胺基羰基、二乙胺基羰基等。 Examples of the C1 to 6 alkylaminocarbonyl group include a methylaminocarbonyl group, a dimethylaminocarbonyl group, and a diethylaminocarbonyl group.

C1~6鹵化烷硫基係於已述之C1~6烷硫基上取代有鹵素基者。作為C1~6鹵化烷硫基,可列舉三氟甲硫基等。 The C1 ~ 6 halogenated alkylthio group is a halogen group substituted on the C1 ~ 6 alkylthio group described above. Examples of the C1 to 6 halogenated alkylthio group include trifluoromethylthio group and the like.

C1~6鹵化烷基亞磺醯基係於已述之C1~6烷基亞磺醯基上 取代有鹵素基者。作為C1~6鹵化烷基亞磺醯基,可列舉三氟甲基亞磺醯基等。 The C1 ~ 6 halogenated alkylsulfinyl sulfenyl group is substituted with the halogen group in the C1 ~ 6 alkyl sulfinyl sulfinyl group already described. Examples of the C1 to 6 halogenated alkylsulfinyl sulfenyl group include trifluoromethylsulfinyl sulfinyl group and the like.

C1~6鹵化烷基磺醯基係於已述之C1~6烷基磺醯基上取代有鹵素基者。作為C1~6鹵化烷基磺醯基,可列舉三氟甲基磺醯基等。 The C1 ~ 6 halogenated alkylsulfonyl group is a halogen group substituted on the C1 ~ 6 alkylsulfonyl group described above. Examples of the C1 to 6 halogenated alkylsulfonyl groups include trifluoromethylsulfonyl groups and the like.

3~10員雜環基羰基係於羰基上取代有上文所述之3~10員雜環基者。作為3~10員雜環基羰基,可列舉:氮雜環丁基羰基、吡咯啶基羰基、哌啶基羰基、啉基羰基、哌基羰基、1,4-二氧雜環己基羰基、氮基羰基(azepanylcarbonyl group)、1,4-二氮基羰基、吡咯基羰基、噻唑基羰基、吡啶基羰基、四氫吡啶基羰基、四氫吡喃基羰基、四氫呋喃基羰基、四氫異喹啉基羰基、十氫異喹啉基羰基等。3~10員雜環基羰基較佳為5~6員雜環基羰基。 The 3- to 10-membered heterocyclic carbonyl group is substituted with the 3- to 10-membered heterocyclic group described above on the carbonyl group. Examples of the 3 to 10-membered heterocyclic carbonyl group include azetidinylcarbonyl, pyrrolidinylcarbonyl, piperidinylcarbonyl, Phenylcarbonyl, piperazine Carbonyl, 1,4-dioxane carbonyl, nitrogen Azepanylcarbonyl group, 1,4-diazepine Carbonyl, pyrrolylcarbonyl, thiazolylcarbonyl, pyridylcarbonyl, tetrahydropyridylcarbonyl, tetrahydropyranylcarbonyl, tetrahydrofurylcarbonyl, tetrahydroisoquinolinylcarbonyl, decahydroisoquinolinylcarbonyl, and the like. The 3- to 10-membered heterocyclic carbonyl group is preferably a 5- to 6-membered heterocyclic carbonyl group.

式:-CRc=NORd表示之基中之Rc中之C1~6烷基係如已述者。 Formula: -CR c = NOR d The C1 ~ 6 alkyl group in R c in the group represented is as already described.

式:-CRc=NORd表示之基中之Rd中之C3~8環烷基係如已述者。 Formula: -CR c = NOR d The C3 ~ 8 cycloalkyl group in R d in the base is as already described.

作為經作為G22之側氧基或伸烷基二氧基取代之C3~8環烷基或C3~8環烯基,可列舉如以下之基。*表示鍵結位置。 Examples of the C 3 to 8 cycloalkyl or C 3 to 8 cycloalkenyl substituted with a pendant oxygen group or an alkylene dioxy group as G 22 include the following groups. * indicates the bonding position.

G22中之3~10員雜環基較佳為5~6員雜環基。 The 3- to 10-membered heterocyclic group in G 22 is preferably a 5- to 6-membered heterocyclic group.

作為G22,較佳為未經取代或經羥基取代之C1~6烷基、C1 ~6鹵化烷基、C2~6烯基、C2~6炔基、C1~6烷氧基、C1~6鹵化烷氧基、C1~6烷基羰基、二C1~6烷基胺基、C1~6烷基胺基羰基、C1~6烷硫基、C1~6鹵化烷硫基、C1~6烷基亞磺醯基、C1~6鹵化烷基亞磺醯基、C1~6烷基磺醯基、C1~6鹵化烷基磺醯基、未經取代或經G221取代之C3~8環烷基、未經取代或經G221取代之C6~10芳基、未經取代或經G221取代之3~10員雜環基、未經取代或經G221取代之3~10員雜環基羰基、五氟硫基、硝基、氰基、鹵素基、側氧基、未經取代或經G211取代之C1~6伸烷基二氧基、-CRc=NORd表示之基,更佳為C1~6烷基、C1~6鹵化烷基、C1~6烷氧基、C1~6鹵化烷氧基、未經取代或經G221取代之C3~8環烷基、未經取代或經G221取代之C6~10芳基、未經取代或經G221取代之3~10員雜環基,尤佳為C1~6烷基、C1~6鹵化烷基、未經取代或經G221取代之環己基、未經取代或經G221取代之苯基、未經取代或經G221取代之5~6員雜環基(較佳為四氫吡喃基、啉基、二氧雜環戊基、呋喃基、噻吩基、吡唑基、吡啶基)。 As G 22 , an unsubstituted or hydroxy-substituted C1 to 6 alkyl group, C1 to 6 halogenated alkyl group, C2 to 6 alkenyl group, C2 to 6 alkynyl group, C1 to 6 alkoxy group, and C1 to 6 are preferable. Halogenated alkoxy, C1 ~ 6 alkylcarbonyl, diC1 ~ 6 alkylamino, C1 ~ 6 alkylaminocarbonyl, C1 ~ 6 alkylthio, C1 ~ 6 halogenated alkylthio, C1 ~ 6 alkyl Sulfinylene, C1 ~ 6 halogenated alkylsulfinyl, C1 ~ 6 alkylsulfinyl, C1 ~ 6 halogenated alkylsulfinyl, C3 ~ 8 cycloalkyl unsubstituted or substituted with G 221 , Unsubstituted or substituted with G 221 C6 ~ 10 aryl, unsubstituted or substituted with G 221 3- to 10-membered heterocyclyl, unsubstituted or substituted with G 221 3- to 10-membered heterocyclyl carbonyl , Pentafluorothio, nitro, cyano, halogen, pendant oxy, unsubstituted or substituted with G 211 C1-6 alkylenedioxy, -CR c = NOR d , more preferably C1 ~ 6 alkyl, C1 ~ 6 halogenated alkyl, C1 ~ 6 alkoxy, C1 ~ 6 halogenated alkoxy, C3 ~ 8 cycloalkyl, unsubstituted or substituted with G 221 , unsubstituted or modified G 221 substituted C6 ~ 10 aryl, unsubstituted or substituted 3 ~ 10 membered heterocyclic group with G 221 , particularly preferably C1 ~ 6 alkyl, C1 ~ 6 haloalkyl, unsubstituted or G 221 Replace Cyclohexyl, unsubstituted or substituted with G 221 , unsubstituted or substituted with G 221 5-membered heterocyclic group (preferably tetrahydropyranyl, (Phenyl, dioxolyl, furyl, thienyl, pyrazolyl, pyridyl).

[G221] [G 221 ]

G221表示C1~6烷基、C1~6鹵化烷基、C1~6烷氧基、C1~6鹵化烷氧基、單C1~6烷基胺基、二C1~6烷基胺基、C6~10芳基或鹵素基。於經G221取代之基存在2個以上之情形時,該G221互相可相同,亦可不同。 G 221 represents C1 to 6 alkyl, C1 to 6 halogenated alkyl, C1 to 6 alkoxy, C1 to 6 halogenated alkoxy, mono C1 to 6 alkylamino, di C1 to 6 alkylamino, C6 ~ 10 aryl or halo. When there are more than two groups substituted by G 221 , the G 221 may be the same as or different from each other.

取代基G221中之C1~6烷基、C1~6鹵化烷基、C1~6烷氧基、C1~6鹵化烷氧基、單C1~6烷基胺基、二C1~6烷基胺基、C6~10芳基、及鹵素基係如已述者。 C1 ~ 6 alkyl, C1 ~ 6 halogenated alkyl, C1 ~ 6 alkoxy, C1 ~ 6 halogenated alkoxy, mono C1 ~ 6 alkylamino, di C1 ~ 6 alkylamine in substituent G 221 The radicals, C6-10 aryl, and halogen radicals are as described above.

作為G221,較佳為C1~6烷基、C1~6鹵化烷基、C1~6烷 氧基、C1~6鹵化烷氧基、鹵素基,尤佳為甲基、三氟甲基、氯基。 G 221 is preferably a C1 to 6 alkyl group, a C1 to 6 halogenated alkyl group, a C1 to 6 alkoxy group, a C1 to 6 halogenated alkoxy group, or a halogen group, particularly preferably a methyl group, a trifluoromethyl group, and a chloro group base.

[R1] [R 1 ]

R1表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C1~6烷氧基、未經取代或經G1取代之C1~6烷氧基羰基、未經取代或經G1取代之C1~6烷硫基、未經取代或經G1取代之C1~6烷基胺基羰基、未經取代或經G2取代之C6~10芳基、氰基或鹵素基。 R 1 represents a hydrogen atom, an unsubstituted or G 1 substituted C1 to 6 alkyl group, an unsubstituted or G 1 substituted C 2 to 6 alkenyl group, an unsubstituted or G 1 substituted C 1 to 6 alkoxy group Group, unsubstituted or G 1 substituted C1 ~ 6 alkoxycarbonyl group, unsubstituted or G 1 substituted C1 ~ 6 alkylthio group, unsubstituted or G 1 substituted C1 ~ 6 alkylamine Carbonyl, unsubstituted or G 2 substituted C6 ~ 10 aryl, cyano or halogen.

R1中之C1~6烷基、C2~6烯基、C1~6烷氧基、C1~6烷氧基羰基、C1~6烷硫基、C1~6烷基胺基羰基、C6~10芳基、鹵素基、取代基G1及取代基G2係如已述者。 R 1 is the C1 ~ 6 alkyl, C2 ~ 6 alkenyl group, C1 ~ 6 alkoxy, C1 ~ 6 alkoxycarbonyl, C1 ~ 6 alkylthio, C1 ~ 6 alkyl-carbonyl group, C6 ~ 10 The aryl group, the halogen group, the substituent G 1 and the substituent G 2 are as described above.

作為R1,較佳為未經取代或經G1取代之C1~6烷基(較佳為未經取代)或者鹵素基,尤佳為甲基或鹵素基。 As R 1 , an unsubstituted or G 1 -substituted C1-6 alkyl group (preferably unsubstituted) or a halogen group is preferable, and a methyl group or a halogen group is particularly preferable.

[R2] [R 2 ]

式(I)中之R2表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G2取代之C3~8環烷基、未經取代或經G1取代之C1~6烷氧基、甲醯氧基、未經取代或經G1取代之C1~6烷基羰氧基、未經取代或經G2取代之C6~10芳基、(未經取代或經G1取代之C1~6烷氧基亞胺基)-C1~6烷基、未經取代或經G2取代之3~10員雜環基C1~6烷基、氰基或鹵素基。 R 2 in formula (I) represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1 to 6 alkyl group, an unsubstituted or G 1 substituted C 2 to 6 alkenyl group, an unsubstituted or G 2 substituted the C3 ~ 8 cycloalkyl, unsubstituted or substituted with G 1 of C1 ~ 6 alkoxy, carboxylic acyl group, unsubstituted or substituted with G 1 of C1 ~ 6 alkylcarbonyloxy, unsubstituted Or C6 ~ 10 aryl substituted with G 2 (C1 ~ 6 alkoxyimino substituted or substituted with G 1 ) -C1 ~ 6 alkyl, 3 ~ unsubstituted or substituted with G 2 10-membered heterocyclic C1-6 alkyl, cyano or halogen.

R2中之C1~6烷基、C2~6烯基、C3~8環烷基、C1~6烷氧基、C1~6烷基羰氧基、C6~10芳基、鹵素基、取代基G1及取代基G2係如已述者。 R 2 in the C1 ~ 6 alkyl, C2 ~ 6 alkenyl, C3 ~ 8 cycloalkyl, C1 ~ 6 alkoxy, C1 ~ 6 alkyl-carbonyl group, C6 ~ 10 aryl group, a halogen group, a substituted group G 1 and the substituent G 2 are as described above.

作為(C1~6烷氧基亞胺基)-C1~6烷基,可列舉:甲氧基亞胺基-甲基、1-(乙氧基亞胺基)-乙基等。 Examples of (C1 to 6 alkoxyimino) -C1 to 6 alkyl include methoxyimino-methyl, 1- (ethoxyimino) -ethyl, and the like.

3~10員雜環基C1~6烷基係於C1~6烷基上取代有上文所述之3~10員雜環基者。作為3~10員雜環基C1~6烷基,較佳可列舉:四氫呋喃基甲基、四氫吡喃基甲基、二氧雜環戊基甲基、二氧雜環己基甲基、吡唑基甲基、吡啶基甲基等。3~10員雜環基C1~6烷基較佳為5~6員雜環基C1~6烷基。 The 3 to 10-membered heterocyclyl C1 to 6 alkyl is substituted on the C1 to 6 alkyl with the 3 to 10 membered heterocyclyl described above. As the 3- to 10-membered heterocyclyl C1-6 alkyl group, preferred examples include tetrahydrofurylmethyl, tetrahydropyranylmethyl, dioxolylmethyl, dioxolylmethyl, and pyridine. Azolylmethyl, pyridylmethyl and the like. The 3 to 10-membered heterocyclyl C1 to 6 alkyl group is preferably a 5 to 6-membered heterocyclyl C1 to 6 alkyl group.

作為R2,較佳為未經取代或經G1取代之C1~6烷基(較佳為未經取代)或者鹵素基,更佳為未經取代或經G1取代之C1~6烷基(較佳為未經取代),尤佳為甲基。 As R 2, it is preferably unsubstituted or substituted with G 1 of C1 ~ 6 alkyl group (preferably unsubstituted), or halogen group, more preferably is unsubstituted or substituted by G 1 of C1 ~ 6 alkyl (Preferably unsubstituted), particularly preferably methyl.

[R3] [R 3 ]

式(I)中,R3表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G2取代之C3~8環烷基、未經取代或經G1取代之C1~6烷氧基、未經取代或經G1取代之C1~6烷基羰基、未經取代或經G1取代之C1~6烷氧基羰基、羧基、甲醯基、甲醯氧基、未經取代或經G1取代之C1~6烷基羰氧基、未經取代或經G2取代之C6~10芳基、未經取代或經G2取代之3~10員雜環基、(未經取代或經G1取代之C1~6烷氧基亞胺基)-C1~6烷基、未經取代或經G1取代之單C1~6烷基胺基、未經取代或經G1取代之二C1~6烷基胺基、氰基或鹵素基。 In the formula (I), R 3 represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1 to 6 alkyl group, an unsubstituted or G 1 substituted C 2 to 6 alkenyl group, an unsubstituted or G 2 substituted the C3 ~ 8 cycloalkyl, unsubstituted or substituted with G 1 of C1 ~ 6 alkoxy, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl-carbonyl group, an unsubstituted or substituted by C1 of G 1 1-6 alkoxycarbonyl, carboxyl, acyl, carboxylic acyl group, unsubstituted or substituted with G 1 of a C1 ~ 6 alkylcarbonyloxy, unsubstituted or substituted with G 2 of the C6 ~ 10 aryl group , unsubstituted or substituted with G 2 of the 3 to 10-membered heterocyclic group, (unsubstituted or substituted with G 1 of C1 ~ 6 alkoxyimino group) -C1 ~ 6 alkyl group, unsubstituted or G 1 substituted mono C1-6 alkylamino, unsubstituted or G 1 substituted C1-6 alkylamino, cyano or halogen.

R3中之C1~6烷基、C2~6烯基、C3~8環烷基、C1~6烷氧基、C1~6烷基羰基、C1~6烷氧基羰基、C1~6烷基羰氧基、C6~10芳基、3~10員雜環基、(C1~6烷氧基亞胺基)-C1~6烷基、單C1~6烷基胺 基、二C1~6烷基胺基、鹵素基、取代基G1及取代基G2係如已述者。 In R 3 of C1 ~ 6 alkyl, C2 ~ 6 alkenyl, C3 ~ 8 cycloalkyl, C1 ~ 6 alkoxy, C1 ~ 6 alkylcarbonyl group, C1 ~ 6 alkoxycarbonyl, C1 ~ 6 alkyl Carbonyloxy, C6 ~ 10 aryl, 3 ~ 10 member heterocyclic group, (C1 ~ 6 alkoxyimino) -C1 ~ 6 alkyl, mono C1 ~ 6 alkylamino, di C1 ~ 6 alkane The aminoamino group, the halogen group, the substituent G 1 and the substituent G 2 are as described above.

R3中之3~10員雜環基較佳為5~6員雜芳基。 The 3- to 10-membered heterocyclic group in R 3 is preferably a 5- to 6-membered heteroaryl group.

作為R3,較佳為未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C1~6烷氧基羰基、羧基、未經取代或經G2取代之C3~8環烷基、未經取代或經G2取代之3~10員雜環基、未經取代或經G1取代之二C1~6烷基胺基,更佳為未經取代或經G1取代之C1~6烷基、未經取代或經G2取代之C3~8環烷基(較佳為未經取代)、未經取代或經G2取代之3~10員雜環基、未經取代或經G1取代之C1~6烷基胺基(較佳為未經取代),尤佳為未經取代或經G1(較佳為鹵素基)取代之C1~6烷基。 As R 3 , an unsubstituted or G 1 substituted C1-6 alkyl group, an unsubstituted or G 1 substituted C1-6 alkoxycarbonyl group, a carboxyl group, an unsubstituted or G 2 substituted C3 ~ 8 cycloalkyl, unsubstituted or G 2 substituted 3 to 10 membered heterocyclic group, unsubstituted or G 1 substituted C 1 to 6 alkylamino group, more preferably unsubstituted or substituted G 1 substituted C1-6 alkyl, unsubstituted or G 2 substituted C3-8 cycloalkyl (preferably unsubstituted), unsubstituted or G 2 substituted 3-10 membered heterocyclic group , unsubstituted or substituted with G 1 of C1 ~ 6 alkyl group (preferably unsubstituted), and particularly preferably an unsubstituted or substituted G 1 (preferably halo-yl) alkyl group of C1 ~ 6 .

[R4] [R 4 ]

式(I)中之R4表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G2取代之C3~8環烷基、未經取代或經G2取代之C6~10芳基C1~6烷基、未經取代或經G2取代之3~10員雜環基C1~6烷基、甲醯基、未經取代或經G1取代之C1~6烷基羰基、未經取代或經G2取代之C3~8環烷基羰基、未經取代或經G1取代之C2~6烯基羰基、未經取代或經G2取代之C6~10芳基羰基、未經取代或經G1取代之C1~6烷氧基羰基、未經取代或經G1取代之C2~6烯氧基羰基、未經取代或經G1取代之C1~6烷基磺醯基、未經取代或經G1取代之C1~6烷基胺基羰基、未經取代或經G1取代之(C1~6烷硫基)羰基、未經取代或經G1取代之C1~6烷基胺基(硫羰基)、或者式(II)表示之有機基。 R 4 in formula (I) represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1 to 6 alkyl group, an unsubstituted or G 1 substituted C 2 to 6 alkenyl group, an unsubstituted or G 1 substituted C2 ~ 6 alkynyl, unsubstituted or G 2 substituted C3 ~ 8 cycloalkyl, unsubstituted or G 2 substituted C6 ~ 10 aryl C1 ~ 6 alkyl, unsubstituted or G 2 Substituted 3 to 10-membered heterocyclyl C1 to 6 alkyl, formamyl, unsubstituted or G 1 substituted C 1 to 6 alkyl carbonyl, unsubstituted or G 2 substituted C 3 to 8 cycloalkyl Carbonyl, unsubstituted or G 1 substituted C2-6 alkenylcarbonyl, unsubstituted or G 2 substituted C6-10 arylcarbonyl, unsubstituted or G 1 substituted C1-6 alkoxycarbonyl , unsubstituted or G 1 of C2 ~ 6 alkenyl substituted oxycarbonyl group, unsubstituted or substituted with G 1 of C1 ~ 6 alkylsulfonyl group, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl aminocarbonyl, unsubstituted or substituted with 1 G of (C1 ~ 6 alkylthio) carbonyl group, a substituted or unsubstituted of C1 ~ 6 alkylamino (thiocarbonyl group) by G, or of formula (II), Of its organic base.

R4中之C1~6烷基、C2~6烯基、C2~6炔基、C3~8環烷 基、C6~10芳基C1~6烷基、3~10員雜環基C1~6烷基、C1~6烷基羰基、C1~6烷氧基羰基、C1~6烷基磺醯基、C1~6烷基胺基羰基、取代基G1及取代基G2係如已述者。 Of R 4 is C1 ~ 6 alkyl, C2 ~ 6 alkenyl group, C2 ~ 6 alkynyl group, C3 ~ 8 cycloalkyl, C6 to 10 aryl group C1 ~ 6 alkyl, 3 to 10-membered heterocyclic group C1 ~ 6 Alkyl, C1 ~ 6 alkylcarbonyl, C1 ~ 6 alkoxycarbonyl, C1 ~ 6 alkylsulfonyl, C1 ~ 6 alkylaminocarbonyl, substituent G 1 and substituent G 2 are as described above .

C3~8環烷基羰基係於羰基上取代有上文所述之C3~8環烷基者。作為C3~8環烷基羰基,可列舉:環丙基羰基、環丁基羰基、環戊基羰基、環己基羰基等。 The C3 ~ 8 cycloalkylcarbonyl group is a carbonyl group substituted with the C3 ~ 8 cycloalkyl group described above. Examples of the C3-8 cycloalkylcarbonyl group include a cyclopropylcarbonyl group, a cyclobutylcarbonyl group, a cyclopentylcarbonyl group, and a cyclohexylcarbonyl group.

C2~6烯基羰基係於羰基上取代有上文所述之C2~6烯基者。作為C2~6烯基羰基,可列舉:乙烯基羰基、1-丙烯基羰基、2-丙烯基羰基(烯丙基羰基)等。 The C2-6 alkenylcarbonyl group is a carbonyl group substituted with the C2-6 alkenyl group described above. Examples of C2 to 6 alkenylcarbonyl include vinylcarbonyl, 1-propenylcarbonyl, 2-propenylcarbonyl (allylcarbonyl), and the like.

C6~10芳基羰基係於羰基上取代有上文所述之C6~10芳基者。作為C6~10芳基羰基,可列舉:苄基、萘甲醯基等。 C6 ~ 10 arylcarbonyl is a carbonyl group substituted with a C6 ~ 10 aryl group as described above. Examples of the C6-10 arylcarbonyl group include a benzyl group and a naphthylmethyl group.

作為C2~6烯氧基羰基,可列舉:乙烯氧基羰基、1-丙烯氧基羰基、2-丙烯氧基羰基(烯丙氧基羰基)等。 Examples of C2 to 6 alkenyloxycarbonyl include vinyloxycarbonyl, 1-propenyloxycarbonyl, 2-propenyloxycarbonyl (allyloxycarbonyl), and the like.

作為(C1~6烷硫基)羰基,可列舉:(甲硫基)羰基、(乙硫基)羰基等。 Examples of the (C1 to 6 alkylthio) carbonyl group include (methylthio) carbonyl, (ethylthio) carbonyl, and the like.

作為C1~6烷基胺基(硫羰基),可列舉:甲基胺基(硫羰基)、二甲胺基(硫羰基)等。 Examples of the C1 to 6 alkylamino group (thiocarbonyl group) include a methylamino group (thiocarbonyl group), a dimethylamino group (thiocarbonyl group), and the like.

式(II)中,*表示鍵結鍵。 In formula (II), * represents a bond.

式(II)中,Ga分別獨立地表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G2取代之C3~8環烷基、或者未經取代或經G2取代之C6~10芳基。 In formula (II), G a each independently represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1 to 6 alkyl group, an unsubstituted or G 1 substituted C 2 to 6 alkenyl group, unsubstituted or substituted G 1 substituted C2 ~ 6 alkynyl, unsubstituted or G 2 substituted C3 ~ 8 cycloalkyl, or unsubstituted or G 2 substituted C6 ~ 10 aryl.

Ga中之C1~6烷基、C2~6烯基、C2~6炔基、C3~8環烷基、C6~10芳基、取代基G1及取代基G2係如已述者。 In G a of C1 ~ 6 alkyl, C2 ~ 6 alkenyl group, C2 ~ 6 alkynyl group, C3 ~ 8 cycloalkyl group, C6 ~ 10 aryl group, a substituted the substituent group G 1 and G 2 are based, as already described.

作為Ga,較佳為氫原子、或者未經取代或經G1取代之C1~6烷基(較佳為未經取代),尤佳為氫原子、或甲基。 As G a , a hydrogen atom or a C1-6 alkyl group (preferably an unsubstituted group) which is unsubstituted or substituted with G 1 is preferred, and a hydrogen atom or a methyl group is particularly preferred.

式(II)中,Gb表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G1取代之C2~6炔基、未經取代或經G2取代之C3~8環烷基、未經取代或經G2取代之C6~10芳基、或者未經取代或經G2取代之3~10員雜環基。 In formula (II), G b represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1 to 6 alkyl group, an unsubstituted or G 1 substituted C 2 to 6 alkenyl group, an unsubstituted or G 1 substituted C2 ~ 6 alkynyl, unsubstituted or G 2 substituted C3 ~ 8 cycloalkyl, unsubstituted or G 2 substituted C6 ~ 10 aryl, or unsubstituted or G 2 substituted 3 ~ 10-membered heterocyclyl.

Gb中之C1~6烷基、C2~6烯基、C2~6炔基、C3~8環烷基、C6~10芳基、3~10員雜環基、取代基G1及取代基G2係如已述者。 C1 to 6 alkyl, C2 to 6 alkenyl, C2 to 6 alkynyl, C3 to 8 cycloalkyl, C6 to 10 aryl, 3 to 10 membered heterocyclic group, substituent G 1 and substituents in G b G 2 is as described.

作為Gb,較佳為氫原子、或者未經取代或經G1取代之C1~6烷基(較佳為未經取代),尤佳為氫原子、甲基、或異丙基。 G b is preferably a hydrogen atom or a C1-6 alkyl group (preferably unsubstituted) which is unsubstituted or substituted with G 1 , and particularly preferably a hydrogen atom, a methyl group, or an isopropyl group.

式(II)中,T表示氧原子、氧基羰基、羰氧基、氧基羰氧基、硫原子、(硫基)羰基、羰基(硫基)、(硫基)羰氧基、氧基羰基(硫基)或-O-C(=O)-N(Gb)-表示之二價基。 In formula (II), T represents an oxygen atom, an oxycarbonyl group, a carbonyloxy group, an oxycarbonyloxy group, a sulfur atom, a (thio) carbonyl group, a carbonyl (thio) group, a (thio) carbonyloxy group, and an oxy group. A divalent group represented by carbonyl (thio) or -OC (= O) -N (G b )-.

作為式(II)表示之基之例,可列舉以下所示者。 Examples of the base represented by formula (II) include the following.

作為R4,較佳為氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C2~6烯基、未經取代或經G2取代之C6~10芳基C1~6烷基、未經取代或經G2取代之3~10員雜環基C1~6烷基、未經取代或經G1取代之C1~6烷基羰基、未經取代或經G2取代之C3~8環烷基羰基、未經取代或經G1取代之C1~6烷氧基羰基、或以下之式所表示之基。 As R 4 , a hydrogen atom, an unsubstituted or G 1 -substituted C 1 to 6 alkyl group, an unsubstituted or G 1 -substituted C 2 to 6 alkenyl group, and an unsubstituted or G 2 substituted C 6 are preferable. ~ 10 aryl C1 ~ 6 alkyl, unsubstituted or G 2 substituted 3 to 10 membered heterocyclyl C1 ~ 6 alkyl, unsubstituted or G 1 substituted C1 ~ 6 alkylcarbonyl, unsubstituted A substituted or G 2 substituted C 3 to 8 cycloalkylcarbonyl group, an unsubstituted or G 1 substituted C 1 to 6 alkoxycarbonyl group, or a group represented by the following formula.

作為R4,更佳為氫原子、未經取代或經G1取代之C1~6烷基羰基(較佳為未經取代)、未經取代或經G2取代之C3~8環烷基羰基(較佳為未經取代)、未經取代或經G1取代之C1~6烷氧基羰基(較佳為未經取代)、或以下之式所表示之基。 R 4 is more preferably a hydrogen atom, an unsubstituted or G 1 -substituted C1-6 alkylcarbonyl group (preferably unsubstituted), or an unsubstituted or G 2 -substituted C3-8 cycloalkylcarbonyl group. (preferably unsubstituted), unsubstituted or substituted with G 1 of C1 ~ 6 alkoxycarbonyl group (preferably unsubstituted), or the following of the group represented by the formula.

作為R4,尤佳為氫原子、甲氧基羰基、乙氧基羰基、乙醯基、乙基羰基、環丙基羰基、或以下之式所表示之基。 R 4 is particularly preferably a hydrogen atom, a methoxycarbonyl group, an ethoxycarbonyl group, an ethylfluorenyl group, an ethylcarbonyl group, a cyclopropylcarbonyl group, or a group represented by the following formula.

[A] [A]

式(I)中之A表示氧原子或式(III)表示之二價有機基之任一者。 A in Formula (I) represents either an oxygen atom or a divalent organic group represented by Formula (III).

式(III)中,*表示鍵結位置。 In formula (III), * represents a bonding position.

式(III)中,R5及R6分別獨立地表示氫原子、未經取代或經G1取代之C1~6烷基、未經取代或經G1取代之C1~6烷氧基、未經取代或經G2取代之C6~10芳氧基、未經取代或經G1取代之烷氧基羰氧基、鹵素基、羥基。R5及R6可相連而與R5及R6所鍵結之碳原子一起形成3~6員環。 In the formula (III), R 5 and R 6 each independently represent a hydrogen atom, an unsubstituted or G 1 -substituted C 1 to 6 alkyl group, an unsubstituted or G 1 substituted C 1 to 6 alkoxy group, or G 2 substituted by a substituted aryloxy group of C6 ~ 10, unsubstituted or substituted with G 1 of the alkoxycarbonyloxy, halogen, hydroxy. R 5 and R 6 may be connected to form a 3- to 6-membered ring together with the carbon atom to which R 5 and R 6 are bonded.

R5及R6中之C1~6烷基、C1~6烷氧基、鹵素基及取代基G1係如已述者。 In the R 5 and R 6 C1 ~ 6 alkyl, C1 ~ 6 alkoxy group, a halogen group and a substituted group G 1 as already described were based.

作為R5,較佳為氫原子、未經取代或經G1取代之C1~6烷基、未經取代之C1~6烷氧基、未經取代或經G2取代之C6~10芳氧基、未經取代之烷氧基羰氧基、鹵素基、羥基,更佳為氫原子、甲基、甲氧基、甲氧基羰氧基、苯氧基、苄氧基,尤佳為氫原子。 As R 5 , a hydrogen atom, an unsubstituted or G 1 -substituted C1 to 6 alkyl group, an unsubstituted C1 to 6 alkoxy group, and an unsubstituted or G 2 substituted C6 to 10 aryloxy group are preferred. Group, unsubstituted alkoxycarbonyloxy group, halogeno group, hydroxyl group, more preferably hydrogen atom, methyl group, methoxy group, methoxycarbonyloxy group, phenoxy group, benzyloxy group, particularly preferably hydrogen atom.

作為R6,較佳為氫原子、未經取代或經G1取代之C1~6烷基、未經取代之C1~6烷氧基、未經取代或經G2取代之C6~10芳氧基、未經取代之烷氧基羰氧基、鹵素基、羥基,更佳為氫原子、甲基、甲氧基、甲氧基羰氧基、苯氧基、苄氧基,尤佳為氫原子。 As R 6 , a hydrogen atom, an unsubstituted or G 1 -substituted C1 to 6 alkyl group, an unsubstituted C1 to 6 alkoxy group, and an unsubstituted or G 2 substituted C6 to 10 aryloxy group are preferred. Group, unsubstituted alkoxycarbonyloxy group, halogeno group, hydroxyl group, more preferably hydrogen atom, methyl group, methoxy group, methoxycarbonyloxy group, phenoxy group, benzyloxy group, particularly preferably hydrogen atom.

[Cy] [Cy]

式(I)中之Cy表示未經取代或經G2取代之C6~10芳基、經G2取代之C3~8環烷基、未經取代或經G2取代之3~10員雜環基、或經G2取代之13員雜芳基。 Cy in the formula (I) represents an unsubstituted or G 2 substituted C6 to 10 aryl group, a G 3 substituted C 3 to 8 cycloalkyl group, an unsubstituted or G 2 substituted 3 to 10 membered heterocyclic ring Or 13-membered heteroaryl substituted with G 2 .

Cy中之C6~10芳基、C3~8環烷基、3~10員雜環基、13員雜芳基、及取代基G2係如已述者。 The C6-10 aryl group, C3-8 cycloalkyl group, 3-10 member heterocyclic group, 13 member heteroaryl group, and substituent G 2 in Cy are as described above.

作為Cy中之3~10員雜環基,較佳為3~6員雜環基,尤佳為5~6員雜環基。 As the 3- to 10-membered heterocyclic group in Cy, a 3- to 6-membered heterocyclic group is preferred, and a 5- to 6-membered heterocyclic group is particularly preferred.

作為Cy,較佳為經G2取代之C6~10芳基、經G2取代之C5~6環烷基、經G2取代之3~6員雜環基,更佳為經G2取代之C6~10芳基(較佳為苯基)、經G2取代之5~6員雜環基(較佳為噻吩基、吡啶基或嘧啶基)。於Cy為苯基時,G2之取代位置較佳為4位。 As Cy, G 2 is preferably substituted by the C6 ~ 10 aryl group, a substituted G 2 via the C5 ~ 6 cycloalkyl, substituted by the G 2 3 ~ 6-membered heterocyclic group, more preferably it is substituted by G 2 C6-10 aryl (preferably phenyl), 5-6 membered heterocyclic group substituted with G 2 (preferably thienyl, pyridyl or pyrimidinyl). When Cy is phenyl, the substitution position of G 2 is preferably the 4-position.

作為Cy中之G2,較佳為未經取代或經G21取代之C1~8烷基、未經取代或經G21取代之C2~6烯基、未經取代或經G21取代之C2~6 炔基、羥基、未經取代或經G21取代之C1~6烷氧基、未經取代或經G21取代之C1~6烷基羰基、未經取代或經G21取代之C1~6烷氧基羰基、未經取代或經G21取代之單C1~6烷基羰基胺基、未經取代或經G21取代之N-(C1~6烷基羰基)-N-(C1~6烷基)胺基、未經取代或經G21取代之N-(C1~6烷基羰基)-N-(C1~6烷氧基羰基)胺基、未經取代或經G21取代之C1~6烷氧基羰氧基、巰基、未經取代或經G21取代之C1~6烷硫基、未經取代或經G21取代之C1~6烷基亞磺醯基、未經取代或經G22取代之C3~8環烷基、未經取代或經G22取代之C3~8環烯基、未經取代或經G22取代之C3~8環烷基羰基胺基羰基、未經取代或經G22取代之C6~10芳基、未經取代或經G22取代之C6~10芳氧基、未經取代或經G22取代之3~10員雜環基、13員雜芳基、未經取代或經G22取代之3~10員雜環氧基、氰基、鹵素基、未經取代或經G21取代之C1~6伸烷基、-CRa=NRb表示之基,更佳為未經取代或經G21取代之C1~8烷基、未經取代或經G21取代之C2~6炔基、未經取代或經G21取代之C1~6烷氧基、未經取代或經G21取代之C1~6烷基羰基、未經取代或經G22取代之C6~10芳基、未經取代或經G22取代之C6~10芳氧基、未經取代或經G22取代之3~10員雜環基、未經取代或經G22取代之3~10員雜環氧基、氰基、鹵素基、未經取代或經G21取代之C1~6伸烷基、-CRa=NRb表示之基,尤佳為未經取代或經G21取代之C1~8烷基、未經取代或經G21取代之C2~6炔基、未經取代或經G21取代之C1~6烷氧基、未經取代或經G21取代之C1~6烷基羰基、未經取代或經G22取代之苯基、未經取代或經G22取代之苯氧基、未經取代或經G22取代之5~6員雜環基(較佳為1,2,4-二唑基、唑基、噻唑基、吡唑基、1,2,4-三唑基、吡啶基、嘧啶基)、 未經取代或經G22取代之5~6員雜環氧基(較佳為吡啶氧基)、氰基、鹵素基、未經取代或經G21取代之C1~6伸烷基、-CRa=NRb表示之基,尤佳為未經取代或經G22取代之苯基、未經取代或經G22取代之5~6員雜環基(較佳為1,2,4-二唑基、唑基、噻唑基、吡唑基、1,2,4-三唑基、吡啶基、嘧啶基)。 As G 2 in Cy, an unsubstituted or G 21 substituted C1-8 alkyl group, an unsubstituted or G 21 substituted C2-6 alkenyl group, and an unsubstituted or G 21 substituted C2 are preferred. ~ 6 alkynyl, hydroxy, unsubstituted or G 21 substituted C1 ~ 6 alkoxy, unsubstituted or G 21 substituted C1 ~ 6 alkylcarbonyl, unsubstituted or G 21 substituted C1 ~ 6 alkoxycarbonyl, unsubstituted or substituted with G 21 mono C1 ~ 6 alkylcarbonylamino, unsubstituted or substituted with G 21 N- (C1 ~ 6 alkylcarbonyl) -N- (C1 ~ 6 alkyl) amino, unsubstituted or substituted with the G 21 N- (C1 ~ 6 alkyl-carbonyl) -N- (C1 ~ 6 alkoxycarbonyl) amino, unsubstituted or substituted with the 21 G C1 ~ 6 alkoxycarbonyloxy, mercapto, unsubstituted or substituted with G 21 C1 ~ 6 alkylthio, unsubstituted or substituted with G 21 C1 ~ 6 alkylsulfinyl sulfenyl, unsubstituted or substituted of G 22 C3 ~ 8 cycloalkyl, unsubstituted or substituted with the G 22 C3 ~ 8 cycloalkenyl group, the unsubstituted or substituted by G 22 C3 ~ 8 cycloalkyl carbonyl amino carbonyl group, an the unsubstituted or substituted by G 22 C6 ~ 10 aryl group, unsubstituted or substituted with the G 22 C6 ~ 10 aryloxy, the unsubstituted or substituted by G 22 3 ~ 10 membered Cycloalkyl group, an aryl group 13 heteroaryl, unsubstituted or substituted with the G 22 3 to 10-membered heterocyclic group, a cyano group, a halogen group, unsubstituted or substituted with G 21 of C1 ~ 6 alkylene group, - The group represented by CR a = NR b is more preferably an unsubstituted or G 21 substituted C1-8 alkyl group, an unsubstituted or G 21 substituted C2-6 alkynyl group, unsubstituted or substituted with G 21 C1 ~ 6 alkoxy, unsubstituted or substituted with G 21 C1 ~ 6 alkylcarbonyl, unsubstituted or substituted with G 22 C6 ~ 10 aryl, unsubstituted or substituted with G 22 C6 ~ 10 aryloxy, 3- to 10-membered heterocyclyl, unsubstituted or substituted with G 22 , 3- to 10-membered heterocyclyl, unsubstituted or substituted with G 22 , cyano, halo, unsubstituted or substituted by group G 21 of C1 ~ 6 alkylene, -CR a = NR b represents the, particularly preferably unsubstituted or substituted with G 21 of C1 ~ 8 alkyl, unsubstituted or substituted C2 via the G 21 ~ 6 alkynyl, unsubstituted or G 21 substituted C1 ~ 6 alkoxy, unsubstituted or G 21 substituted C1 ~ 6 alkylcarbonyl, unsubstituted or G 22 substituted phenyl, unsubstituted Substituted or substituted G 22 phenoxy, unsubstituted or substituted G 22 5-membered heterocyclic group (preferably 1, 2, 4- Oxazolyl, (Oxazolyl, thiazolyl, pyrazolyl, 1,2,4-triazolyl, pyridyl, pyrimidinyl), 5- to 6-membered heterocyclic oxo (preferably pyridyloxy) unsubstituted or substituted with G 22 group), a cyano group, a halogen group, unsubstituted or substituted with G alkylene of C1 ~ 6 21, -CR a = NR b represents the group, particularly preferably an unsubstituted or G 22 is the substituted phenyl, unsubstituted or substituted with the G 22 5 ~ 6 membered heterocyclic group (preferably 1,2,4 Oxazolyl, (Oxazolyl, thiazolyl, pyrazolyl, 1,2,4-triazolyl, pyridyl, pyrimidinyl).

於本發明之吡啶化合物中亦包含水合物、各種溶劑合物或多晶型等。進而,本發明之吡啶化合物包含基於不對稱碳原子、雙鍵等之立體異構物及該等之混合物、互變異構物。又,本發明之吡啶化合物亦包含其N-氧化物。此處,所謂N-氧化物係式(I)之吡啶環之氮原子經氧化之化合物。 The pyridine compounds of the present invention also include hydrates, various solvates, polymorphs, and the like. Furthermore, the pyridine compound of the present invention includes stereoisomers based on asymmetric carbon atoms, double bonds, and the like, and mixtures and tautomers thereof. The pyridine compound of the present invention also includes its N-oxide. Here, the N-oxide is a compound in which the nitrogen atom of the pyridine ring of the formula (I) is oxidized.

[互變異構物] [Tautomers]

本發明之吡啶化合物於R4為氫原子之情形時,產生如以下所示之互變異構物(吡啶-4-酮化合物)。再者,式中之R1、R2、R3、A及Cy表示與式(I)中之規定相同之含義。本發明之吡啶化合物包含該互變異構物。 When the pyridine compound of the present invention in the case of R 4 is the hydrogen atom, as shown below to produce the tautomer (pyridin-4-one compound). In addition, R 1 , R 2 , R 3 , A, and Cy in the formulae have the same meanings as defined in the formula (I). The pyridine compound of the present invention contains the tautomer.

[立體異構物] [Stereoisomers]

本發明雖然係以同一結構式所表示之化合物,但包含結構中之原子或取代基之空間配置不同之化合物,例如光學異構物、非鏡像異構物、幾何異構物等全部立體異構物。本發明之吡啶化合物可為一種立體異構物,亦 可為複數立體異構物之混合物。 Although the present invention is a compound represented by the same structural formula, it includes compounds with different spatial arrangements of atoms or substituents in the structure, such as all stereoisomers such as optical isomers, non-image isomers, and geometric isomers. Thing. The pyridine compound of the present invention may be a stereoisomer or a mixture of plural stereoisomers.

[鹽] [Salt]

作為本發明之化合物(I)之鹽,只要為農園藝學上容許之鹽,則無特別限制。例如可列舉:鹽酸、硫酸等無機酸之鹽;乙酸、乳酸等有機酸之鹽;鋰、鈉、鉀等鹼金屬之鹽;鈣、鎂等鹼土金屬之鹽;鐵、銅等過渡金屬之鹽;氨、三乙胺、三丁胺、吡啶、肼等有機鹼之鹽等。化合物(I)之鹽可藉由公知之手法,由化合物(I)獲得。 The salt of the compound (I) of the present invention is not particularly limited as long as it is a salt acceptable in agriculture and horticulture. Examples include salts of inorganic acids such as hydrochloric acid and sulfuric acid; salts of organic acids such as acetic acid and lactic acid; salts of alkali metals such as lithium, sodium, and potassium; salts of alkaline earth metals such as calcium and magnesium; salts of transition metals such as iron and copper ; Ammonia, triethylamine, tributylamine, pyridine, hydrazine and other organic base salts. The salt of the compound (I) can be obtained from the compound (I) by a known method.

[製劑配方] [Formulation]

本發明之農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑並不特別限定於劑型。例如,可列舉水合劑、乳劑、粉劑、粒劑、水溶劑、懸浮劑、顆粒水合劑、錠劑等劑型。製備成製劑之方法並無特別限制,可根據劑形採用公知之製備方法。 The agricultural and horticultural fungicides, pest control agents, and insecticides or acaricides of the present invention are not particularly limited to dosage forms. Examples include dosage forms such as hydration agents, emulsions, powders, granules, aqueous solvents, suspensions, granule hydration agents, and lozenges. The method for preparing the preparation is not particularly limited, and a known preparation method can be adopted according to the dosage form.

以下示出若干製劑實施例。再者,以下所示之製劑配方僅為例示,可於不違反本發明之主旨之範圍內進行修正,本發明並不受以下之製劑實施例任何限制。只要無特別說明,則「份」意指「重量份」。 Several formulation examples are shown below. In addition, the formulation formulations shown below are merely examples, and can be modified within a range that does not violate the gist of the present invention, and the present invention is not limited in any way by the following formulation examples. Unless otherwise specified, "part" means "part by weight".

(製劑1:水合劑) (Formulation 1: Hydrating agent)

將以上物質混合均勻並粉碎成微細狀,而獲得有效成分40%之水合劑。 The above materials are mixed uniformly and pulverized into a fine shape to obtain a hydrating agent with an active ingredient of 40%.

(製劑2:乳劑) (Preparation 2: Emulsion)

將以上物質混合,而獲得有效成分30%之乳劑。 The above substances are mixed to obtain an emulsion with 30% of active ingredients.

(製劑3:粉劑) (Formulation 3: powder)

將以上物質混合均勻並粉碎成微細狀,而獲得有效成分10%之粉劑。 The above materials are mixed uniformly and pulverized into a fine shape to obtain a powder with 10% of an active ingredient.

(製劑4:粒劑) (Formulation 4: Granules)

將以上物質充分粉碎並混合,添加水並充分混練後,進行造粒乾燥而獲得有效成分5%之粒劑。 The above substances were sufficiently pulverized and mixed, water was added and thoroughly kneaded, and then granulation and drying were performed to obtain granules with an active ingredient of 5%.

(製劑5:懸浮劑) (Formulation 5: Suspension)

將以上物質混合,進行濕式粉碎直至粒度成為3微米以下為止,而獲得有效成分10%之懸浮劑。 The above materials were mixed and wet-pulverized until the particle size became 3 micrometers or less, and a suspending agent with 10% of the active ingredient was obtained.

(製劑6:顆粒水合劑) (Formulation 6: Granular Hydrating Agent)

將以上物質混合均勻並粉碎成微細狀後,添加適量之水後進行捏合而製成黏土狀。將黏土狀物造粒後加以乾燥,而獲得有效成分40%之顆粒水合劑。 After the above materials are mixed uniformly and pulverized into a fine shape, an appropriate amount of water is added and kneaded to make a clay shape. The clay is granulated and dried to obtain a granular hydrating agent with an active ingredient of 40%.

繼而,示出化合物實施例,對本發明進一步進行具體說明。但本發明並不受以下化合物實施例任何限制。 Next, compound examples are shown to further specifically explain the present invention. However, the present invention is not limited in any way by the following compound examples.

[實施例1] [Example 1]

(2,3,6-三甲基-5-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)-4-吡啶基)碳酸甲酯(化合物編號:1-3)之製造 (2,3,6-trimethyl-5-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) -4-pyridyl) methyl carbonate (compound number: 1-3) manufacturing

(步驟1)4-苄氧基-2,6-二甲基-3-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)吡啶(化合物編號:1-13)之合成 (Step 1) 4-benzyloxy-2,6-dimethyl-3-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) pyridine (Compound No .: 1 -13) Synthesis

於經乾燥之燒瓶中添加鋅554mg,以氮對系統內進行置換。添加四氫呋喃6ml及1,2-二溴乙烷0.04ml,加熱至60℃。放置冷卻至室溫後,添加氯三甲基矽烷0.02ml,於室溫下攪拌10分鐘。於冰浴冷卻下,於該液中滴加使1-(溴甲基)-4-(4-(三氟甲氧基)苯氧基)苯1.80g溶解於四氫呋喃1.1ml中所獲得之溶液。滴加結束後,於冰浴冷卻下攪拌10分鐘,進而於室溫下攪拌2小時,而製備鋅試劑。 554 mg of zinc was added to the dried flask, and the inside of the system was replaced with nitrogen. Add 6 ml of tetrahydrofuran and 0.04 ml of 1,2-dibromoethane, and heat to 60 ° C. After leaving to cool to room temperature, 0.02 ml of chlorotrimethylsilane was added and stirred at room temperature for 10 minutes. Under ice-cooling, a solution obtained by dissolving 1.80 g of 1- (bromomethyl) -4- (4- (trifluoromethoxy) phenoxy) benzene in 1.1 ml of tetrahydrofuran was added dropwise to the solution. . After the dropwise addition was completed, the mixture was stirred under ice-cooling for 10 minutes, and further stirred at room temperature for 2 hours to prepare a zinc reagent.

於經乾燥之燒瓶中添加4-苄氧基-3-碘-2,6-二甲基吡啶1.55g及二氯雙(三苯基膦)鈀0.16g,以氮對系統內進行置換。其後,於其中添加四氫呋喃10ml。於該液中添加上述鋅試劑,並加熱回流3天。將反應液冷卻至室溫。其後,注入至飽和氯化銨水溶液中,藉由乙酸乙酯進行萃取,並藉由無水硫酸鎂對有機層加以乾燥。於減壓下將溶劑蒸餾除去,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對殘渣進行精製,而獲得目標化合物0.56g。產率為26%。目標化合物之NMR分析之結果如以下所述。 1.55 g of 4-benzyloxy-3-iodo-2,6-dimethylpyridine and 0.16 g of dichlorobis (triphenylphosphine) palladium were added to the dried flask, and the system was replaced with nitrogen. Thereafter, 10 ml of tetrahydrofuran was added thereto. The above-mentioned zinc reagent was added to this solution, and heated under reflux for 3 days. The reaction was cooled to room temperature. Thereafter, it was poured into a saturated aqueous ammonium chloride solution, extracted with ethyl acetate, and the organic layer was dried with anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 0.56 g of the target compound. The yield is 26%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)2.48(s,3H),2.49(s,3H),4.02(s,2H),5.09(s,2H),6.63(s,1H),6.87-6.96(m,4H),7.08-7.15(m,4H),7.26-7.33(m,5H) 1 H-NMR (CDCl 3 , δ ppm) 2.48 (s, 3H), 2.49 (s, 3H), 4.02 (s, 2H), 5.09 (s, 2H), 6.63 (s, 1H), 6.87-6.96 ( m, 4H), 7.08-7.15 (m, 4H), 7.26-7.33 (m, 5H)

(步驟2)2,6-二甲基-3-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)吡啶-4-醇(化合物編號:1-14)之合成 (Step 2) 2,6-dimethyl-3-(((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) pyridin-4-ol (Compound No .: 1-14 Synthesis of)

將4-苄氧基-2,6-二甲基-3-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)吡啶0.56g、甲醇10ml、及10%鈀碳0.10g加以混合,於氫環境下、室溫下攪拌一晚。藉由過濾除去不溶物,於減壓下將溶劑從濾液中蒸餾除去,而獲得目標化合物0.38g。產率為85%。目標化合物之NMR分析之結果如以下所述。 0.56 g of 4-benzyloxy-2,6-dimethyl-3-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) pyridine, 10 ml of methanol, and 10 0.10 g of% palladium on carbon was mixed and stirred overnight under a hydrogen atmosphere at room temperature. The insoluble matter was removed by filtration, and the solvent was distilled off from the filtrate under reduced pressure to obtain 0.38 g of the target compound. The yield was 85%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CD3OD,δ ppm)2.28(s,3H),2.30(s,3H),3.90(s,2H),6.25(s,1H),6.89-7.00(m,4H),7.19-7.23(m,4H) 1 H-NMR (CD 3 OD, δ ppm) 2.28 (s, 3H), 2.30 (s, 3H), 3.90 (s, 2H), 6.25 (s, 1H), 6.89-7.00 (m, 4H), 7.19 -7.23 (m, 4H)

(步驟3)3-碘-2,6-二甲基-5-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)吡啶-4-醇(化合物編號:1-15)之合成 (Step 3) 3-iodo-2,6-dimethyl-5-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) pyridin-4-ol (Compound No. : 1-15) Synthesis

將2,6-二甲基-3-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)吡啶-4-醇0.38g、乙酸7ml、及N-碘代琥珀醯亞胺225mg加以混合,於室溫下攪拌2小時。藉由過濾採集所析出之固體,藉由少量之乙酸及乙腈進行洗淨,而獲得目標化合物0.18g。產率為36%。目標化合物之NMR分析之結果如以下所述。 0.38 g of 2,6-dimethyl-3-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) pyridin-4-ol, 7 ml of acetic acid, and N-iodine 225 mg of succinimidine was mixed and stirred at room temperature for 2 hours. The precipitated solid was collected by filtration, and washed with a small amount of acetic acid and acetonitrile to obtain 0.18 g of the target compound. The yield was 36%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CD3OD,δ ppm)2.30(s,3H),2.58(s,3H),3.96(s,2H),6.89-7.00(m,4H),7.19-7.23(m,4H) 1 H-NMR (CD 3 OD, δ ppm) 2.30 (s, 3H), 2.58 (s, 3H), 3.96 (s, 2H), 6.89-7.00 (m, 4H), 7.19-7.23 (m, 4H)

(步驟4)(3-碘-2,6-二甲基-5-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)4-吡啶基)碳酸甲酯(化合物編號:1-16)之合成 (Step 4) (3-iodo-2,6-dimethyl-5-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) 4-pyridyl) methyl carbonate Synthesis of Esters (Compound No .: 1-16)

於3-碘-2,6-二甲基-5-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)吡啶-4-醇0.49g中添加氯仿10ml、三乙胺0.19g。於冰浴冷卻下,於該反應液中滴加氯甲酸甲酯0.14g,於室溫下攪拌一晚。將反應液注入至飽和碳酸氫鈉水中,藉由氯仿進行萃取。藉由無水硫酸鎂對有機層加以乾燥。於減壓下將溶劑蒸餾除去,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對殘渣進行精製,而獲得目標化合物0.48g。產率為88%。目標化合物之NMR分析之結果如以下所述。 10 ml of chloroform was added to 0.49 g of 3-iodo-2,6-dimethyl-5-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) pyridin-4-ol. And 0.19 g of triethylamine. Under ice-cooling, 0.14 g of methyl chloroformate was added dropwise to the reaction solution, and the mixture was stirred at room temperature overnight. The reaction solution was poured into saturated sodium bicarbonate water, and extracted with chloroform. The organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 0.48 g of the target compound. The yield was 88%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)2.49(s,3H),2.77(s,3H),3.84(s,3H),3.97(s,2H),6.90-6.97(m,4H),7.07-7.17(m,4H) 1 H-NMR (CDCl 3 , δ ppm) 2.49 (s, 3H), 2.77 (s, 3H), 3.84 (s, 3H), 3.97 (s, 2H), 6.90-6.97 (m, 4H), 7.07- 7.17 (m, 4H)

(步驟5)(2,3,6-三甲基-5-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)-4-吡啶基)碳酸甲酯(化合物編號:1-3)之合成 (Step 5) (2,3,6-trimethyl-5-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) -4-pyridyl) methyl carbonate (Compound No .: 1-3) Synthesis

將(3-碘-2,6-二甲基-5-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)4-吡啶基)碳酸甲酯0.48g溶解於1,2-二甲氧基乙烷10ml中,於該溶液中添加雙(二三級丁基(4-二甲胺基苯基)膦)二氯化鈀60mg、碳酸鉀0.24g、及三甲基硼氧烴三聚物0.21g。以氮對系統內進行置換,並加熱回流1小時。將反應液冷卻至室溫。其後,將其注入至飽和氯化銨水溶液中,藉由乙酸乙酯進行萃取。 藉由無水硫酸鎂對有機層加以乾燥。於減壓下將溶劑蒸餾除去,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對殘渣進行精製,而獲得目標化合物0.31g。產率為80%。目標化合物之NMR分析之結果如以下所述。 0.48 g of (3-iodo-2,6-dimethyl-5-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) 4-pyridyl) methyl carbonate It was dissolved in 10 ml of 1,2-dimethoxyethane, and 60 mg of bis (di-tertiary-butyl (4-dimethylaminophenyl) phosphine) palladium dichloride, 0.24 g of potassium carbonate, and And 0.21 g of trimethyl borohydride terpolymer. The inside of the system was replaced with nitrogen and heated under reflux for 1 hour. The reaction was cooled to room temperature. Thereafter, this was poured into a saturated aqueous ammonium chloride solution, and extraction was performed with ethyl acetate. The organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 0.31 g of the target compound. The yield was 80%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)2.10(s,3H),2.48(s,3H),2.51(s,3H),3.79(s,3H),3.92(s,2H),6.89-6.97(m,4H),7.08(d,2H),7.15(d,2H) 1 H-NMR (CDCl 3 , δ ppm) 2.10 (s, 3H), 2.48 (s, 3H), 2.51 (s, 3H), 3.79 (s, 3H), 3.92 (s, 2H), 6.89-6.97 ( m, 4H), 7.08 (d, 2H), 7.15 (d, 2H)

[實施例2] [Example 2]

(2-異丙基-5,6-二甲基-3-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)-4-吡啶基)碳酸甲酯(化合物編號:1-9)之製造 (2-isopropyl-5,6-dimethyl-3-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) -4-pyridyl) methyl carbonate (Compound No .: 1-9) Manufacturing

(步驟1)4-羥基-2-異丙基-5,6-二甲基菸鹼酸甲酯之合成 (Step 1) Synthesis of 4-hydroxy-2-isopropyl-5,6-dimethylnicotinic acid methyl ester

將3-胺基-4-甲基-2-戊烯酸甲酯13.0g、2,2,5,6-四甲基-4H-1,3-二氧雜環己烯-4-酮15.6g、及分子篩4A 18.2g加以混合,於170℃攪拌20分鐘。於該反應液中添加甲醇。其後,將反應液進行過濾,於減壓下將溶劑從濾液中蒸餾除去。於所獲得之殘渣中添加二乙醚,藉由過濾採集所析出之結晶,而獲得目標化合物6.98g。產率為34%。目標化合物之NMR分析之結果如以下所述。 13.0 g of 3-amino-4-methyl-2-pentenoic acid methyl ester, 2,2,5,6-tetramethyl-4H-1,3-dioxetan-4-one 15.6 g, and 18.2 g of molecular sieve 4A were mixed and stirred at 170 ° C for 20 minutes. Methanol was added to this reaction liquid. Thereafter, the reaction solution was filtered, and the solvent was distilled off from the filtrate under reduced pressure. Diethyl ether was added to the obtained residue, and the precipitated crystals were collected by filtration to obtain 6.98 g of the target compound. The yield was 34%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(DMSO-d6,δ ppm)1.20(d,6H),1.80(s,3H),2.26(s,3H),3.70(s,3H),10.57(br.s,1H) 1 H-NMR (DMSO-d6, δ ppm) 1.20 (d, 6H), 1.80 (s, 3H), 2.26 (s, 3H), 3.70 (s, 3H), 10.57 (br.s, 1H)

(步驟2)6-異丙基-2,3-二甲基吡啶-4-醇之合成 (Step 2) Synthesis of 6-isopropyl-2,3-dimethylpyridin-4-ol

將4-羥基-2-異丙基-5,6-二甲基菸鹼酸甲酯2.56g溶解於N-甲基-2-吡咯啶酮11ml中。於該溶液中添加氯化鋰4.86g,於180℃攪拌3小時。將該反應液冷卻至室溫。其後,注入至飽和氯化銨水溶液中,藉由氯仿進行萃取。藉由無水硫酸鎂對有機層加以乾燥。於減壓下將溶劑蒸餾除去,藉由矽膠管柱層析法(展開溶劑:氯仿/甲醇)對殘渣進行精製,而獲得目標化合物1.49g。產率為79%。目標化合物之NMR分析之結果如以下所述。 2.56 g of 4-hydroxy-2-isopropyl-5,6-dimethyl nicotinic acid methyl ester was dissolved in 11 ml of N-methyl-2-pyrrolidone. To this solution was added 4.86 g of lithium chloride, followed by stirring at 180 ° C for 3 hours. The reaction liquid was cooled to room temperature. Then, it poured into the saturated aqueous ammonium chloride solution, and extracted with chloroform. The organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solvent: chloroform / methanol) to obtain 1.49 g of the target compound. The yield was 79%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CD3OD,δ ppm)1.27(d,6H),1.99(s,3H),2.36(s,3H),2.79-2.85(m,1H),6.23(s,1H) 1 H-NMR (CD 3 OD, δ ppm) 1.27 (d, 6H), 1.99 (s, 3H), 2.36 (s, 3H), 2.79-2.85 (m, 1H), 6.23 (s, 1H)

(步驟3)3-碘-2-異丙基-5,6-二甲基吡啶-4-醇之合成 (Step 3) Synthesis of 3-iodo-2-isopropyl-5,6-dimethylpyridin-4-ol

將6-異丙基-2,3-二甲基吡啶-4-醇1.60g混合於氯仿32ml、甲醇8ml及N-碘代琥珀醯亞胺2.40g中,於室溫下攪拌3小時。藉由過濾採集所析出之固體,並藉由少量之乙腈及二乙醚進行洗淨,而獲得目標化合物1.60g。產率為57%。目標化合物之NMR分析之結果如以下所述。 1.60 g of 6-isopropyl-2,3-dimethylpyridin-4-ol was mixed with 32 ml of chloroform, 8 ml of methanol, and 2.40 g of N-iodosuccinimide, and stirred at room temperature for 3 hours. The precipitated solid was collected by filtration, and washed with a small amount of acetonitrile and diethyl ether to obtain 1.60 g of the target compound. The yield was 57%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CD3OD,δ ppm)1.30(d,6H),2.06(s,3H),2.39(s,3H),3.60-3.69(m,1H) 1 H-NMR (CD 3 OD, δ ppm) 1.30 (d, 6H), 2.06 (s, 3H), 2.39 (s, 3H), 3.60-3.69 (m, 1H)

(步驟4)4,4,5,5-四甲基-2-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)-1,3,2-二氧雜硼烷之合成 (Step 4) 4,4,5,5-tetramethyl-2-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) -1,3,2-di Synthesis of oxaborane

將雙(頻那醇酯)二硼烷(bis(pinacolato)diboron)10.5g、四(三苯基膦)鈀2.0g、及碳酸鉀14.3g加以混合。於其中添加1,4-二烷100ml及1-(溴甲基)-4-(4-(三氟甲氧基)苯氧基)苯12.0g,以氮對系統內進行置換,並加熱回流5小時。將反應液冷卻至室溫。其後,藉由過濾除去不溶物,於減壓下將溶劑從濾液中蒸餾除去。藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對所獲得之殘渣進行精製,而獲得目標化合物5.46g。產率為40%。目標化合物之NMR分析之結果如以下所述。 10.5 g of bis (pinacolato) diboron, 2.0 g of tetrakis (triphenylphosphine) palladium, and 14.3 g of potassium carbonate were mixed. Add 1,4-two to it 100 ml of alkane and 12.0 g of 1- (bromomethyl) -4- (4- (trifluoromethoxy) phenoxy) benzene were substituted in the system with nitrogen, and heated under reflux for 5 hours. The reaction was cooled to room temperature. Then, insoluble matter was removed by filtration, and the solvent was distilled off from the filtrate under reduced pressure. The obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 5.46 g of the target compound. The yield is 40%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.23(s,12H),2.28(s,2H),6.88-6.98(m,4H),7.13-7.18(m,4H) 1 H-NMR (CDCl 3 , δ ppm) 1.23 (s, 12H), 2.28 (s, 2H), 6.88-6.98 (m, 4H), 7.13-7.18 (m, 4H)

(步驟5)2-異丙基-5,6-二甲基-3-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)吡啶-4-醇(化合物編號:1-8)之合成 (Step 5) 2-isopropyl-5,6-dimethyl-3-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) pyridin-4-ol ( Synthesis of compound number: 1-8)

將3-碘-2-異丙基-5,6-二甲基吡啶-4-醇0.30g、雙(二三級丁基(4-二甲胺基苯基)膦)二氯化鈀73mg、及碳酸鉀0.43g加以混合。於其中添加1,4-二烷5ml、4,4,5,5-四甲基-2-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)-1,3,2-二氧雜硼烷 0.49g、及水1ml,以氮對系統內進行置換,並加熱回流2小時。將反應液冷卻至室溫。其後,注入至飽和氯化銨水溶液中,藉由乙酸乙酯進行萃取,並藉由無水硫酸鎂對有機層加以乾燥。於減壓下將溶劑蒸餾除去,藉由矽膠管柱層析法(展開溶劑:氯仿/甲醇)對所獲得之殘渣進行精製,而獲得目標化合物0.08g。產率為18%。目標化合物之NMR分析之結果如以下所述。 0.30 g of 3-iodo-2-isopropyl-5,6-dimethylpyridin-4-ol, 73 mg of bis (di-tert-butyl (4-dimethylaminophenyl) phosphine) palladium dichloride And 0.43 g of potassium carbonate were mixed. Add 1,4-two to it 5ml, 4,4,5,5-tetramethyl-2-(((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) -1,3,2-dioxane 0.49 g of heteroborane and 1 ml of water were substituted in the system with nitrogen, and heated under reflux for 2 hours. The reaction was cooled to room temperature. Thereafter, it was poured into a saturated aqueous ammonium chloride solution, extracted with ethyl acetate, and the organic layer was dried with anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: chloroform / methanol) to obtain 0.08 g of the target compound. The yield was 18%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.15(d,6H),2.04(s,3H),2.29(s,3H),3.18-3.27(m,1H),3.98(s,2H),6.85-6.94(m,4H),7.11-7.21(m,4H),7.96(br.s,1H) 1 H-NMR (CDCl 3 , δ ppm) 1.15 (d, 6H), 2.04 (s, 3H), 2.29 (s, 3H), 3.18-3.27 (m, 1H), 3.98 (s, 2H), 6.85 6.94 (m, 4H), 7.11-7.21 (m, 4H), 7.96 (br.s, 1H)

(步驟6)(2-異丙基-5,6-二甲基-3-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)-4-吡啶基)碳酸甲酯(化合物編號:1-9)之合成 (Step 6) (2-isopropyl-5,6-dimethyl-3-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) -4-pyridyl ) Synthesis of methyl carbonate (compound number: 1-9)

於2-異丙基-5,6-二甲基-3-((4-(4-(三氟甲氧基)苯氧基)苯基)甲基)吡啶-4-醇0.15g中添加氯仿8ml及三乙胺71mg。於冰浴冷卻下向該反應液中滴加氯甲酸甲酯50mg,於室溫下攪拌2小時。將反應液注入至飽和碳酸氫鈉水中,藉由氯仿進行萃取。藉由無水硫酸鎂對有機層加以乾燥。於減壓下將溶劑蒸餾除去,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對所獲得之殘渣進行精製,而獲得目標化合物0.10g。產率為59%。目標化合物之NMR分析之結果如以下所述。 Added to 0.15 g of 2-isopropyl-5,6-dimethyl-3-((4- (4- (trifluoromethoxy) phenoxy) phenyl) methyl) pyridin-4-ol 8 ml of chloroform and 71 mg of triethylamine. 50 mg of methyl chloroformate was added dropwise to the reaction solution under ice-cooling, and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into saturated sodium bicarbonate water, and extracted with chloroform. The organic layer was dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 0.10 g of the target compound. The yield was 59%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.17(d,6H),2.08(s,3H),2.51(s,3H),3.19-3.22(m, 1H),3.76(s,3H),3.95(s,2H),6.89-6.94(m,4H),7.06-7.15(m,4H) 1 H-NMR (CDCl 3 , δ ppm) 1.17 (d, 6H), 2.08 (s, 3H), 2.51 (s, 3H), 3.19-3.22 (m, 1H), 3.76 (s, 3H), 3.95 ( s, 2H), 6.89-6.94 (m, 4H), 7.06-7.15 (m, 4H)

[實施例3] [Example 3]

2-異丙基-5,6-二甲基-3-(4-(5-(三氟甲基)-1,2,4-二唑-3-基)苄基)吡啶-4-基碳酸甲酯之製造 2-isopropyl-5,6-dimethyl-3- (4- (5- (trifluoromethyl) -1,2,4- Diazol-3-yl) benzyl) pyridin-4-ylmethyl carbonate

(步驟1)2-異丙基-4-甲氧基-5,6-二甲基菸鹼酸甲酯之合成 (Step 1) Synthesis of methyl 2-isopropyl-4-methoxy-5,6-dimethylnicotinate

將4-羥基-2-異丙基-5,6-二甲基菸鹼酸甲酯20g、碳酸鉀24.8g、碘甲烷25.4g、及乙腈300ml加以混合,並加熱回流3小時。藉由矽藻土過濾反應液,於減壓下將溶劑蒸餾除去。藉由乙酸乙酯稀釋所獲得之殘渣並進行水洗後,於減壓下將溶劑蒸餾除去,而獲得目標化合物21.3g。產率為100%。目標化合物之NMR分析之結果如以下所述。 20 g of methyl 4-hydroxy-2-isopropyl-5,6-dimethylnicotinate, 24.8 g of potassium carbonate, 25.4 g of methyl iodide, and 300 ml of acetonitrile were mixed and heated under reflux for 3 hours. The reaction solution was filtered through celite, and the solvent was distilled off under reduced pressure. The obtained residue was diluted with ethyl acetate and washed with water, and then the solvent was distilled off under reduced pressure to obtain 21.3 g of the target compound. The yield is 100%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.25(d,6H),2.17(s,3H),2.49(s,3H),2.93(m,1H),3.79(s,3H),3.92(s,3H). 1 H-NMR (CDCl 3 , δ ppm) 1.25 (d, 6H), 2.17 (s, 3H), 2.49 (s, 3H), 2.93 (m, 1H), 3.79 (s, 3H), 3.92 (s, 3H).

(步驟2)(2-異丙基-4-甲氧基-5,6-二甲基吡啶-3-基)甲醇之合成 (Step 2) Synthesis of (2-isopropyl-4-methoxy-5,6-dimethylpyridin-3-yl) methanol

將四氫呋喃250ml、鋁氫化鋰4.08g加以混合,並冷卻為-10℃。於該 混合液中滴加將2-異丙基-4-甲氧基-5,6-二甲基菸鹼酸甲酯21.3g溶解於四氫呋喃90ml中而成之溶液。滴加結束後,升溫為30℃,再次冷卻為0℃。重複該操作,直至藉由薄層層析法確認2-異丙基-4-甲氧基-5,6-二甲基菸鹼酸甲酯之消失。將反應液進行冰浴冷卻,依序添加水4.08g、15%氫氧化鈉水溶液4.08g、水12.2g後,藉由矽藻土進行過濾,並於減壓下將溶劑蒸餾除去,而獲得目標化合物17.5g。產率為93%。目標化合物之NMR分析之結果如以下所述。 250 ml of tetrahydrofuran and 4.08 g of lithium aluminum hydride were mixed and cooled to -10 ° C. A solution prepared by dissolving 21.3 g of methyl 2-isopropyl-4-methoxy-5,6-dimethylnicotinate in 90 ml of tetrahydrofuran was added dropwise to the mixed solution. After completion of the dropwise addition, the temperature was raised to 30 ° C, and then cooled to 0 ° C again. This operation was repeated until the disappearance of methyl 2-isopropyl-4-methoxy-5,6-dimethylnicotinate was confirmed by thin layer chromatography. The reaction solution was cooled in an ice bath, 4.08 g of water, 4.08 g of 15% aqueous sodium hydroxide solution, and 12.2 g of water were sequentially added, and then filtered through celite, and the solvent was distilled off under reduced pressure to obtain the target Compound 17.5g. The yield was 93%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.27(d,6H),1.83(m,1H),2.17(s,3H),2.47(s,3H),3.33(m,1H),3.81(s,3H),4.74(d,2H). 1 H-NMR (CDCl 3 , δ ppm) 1.27 (d, 6H), 1.83 (m, 1H), 2.17 (s, 3H), 2.47 (s, 3H), 3.33 (m, 1H), 3.81 (s, 3H), 4.74 (d, 2H).

(步驟3)3-(溴甲基)-2-異丙基-4-甲氧基-5,6-二甲基吡啶之合成 (Step 3) Synthesis of 3- (bromomethyl) -2-isopropyl-4-methoxy-5,6-dimethylpyridine

將(2-異丙基-4-甲氧基-5,6-二甲基吡啶-3-基)甲醇15.7g、四溴化碳42.5g溶解於二氯甲烷300ml中。於室溫下逐量添加三苯基膦25.7g後,於室溫下攪拌一晚。藉由碳酸氫鈉水將該反應液洗淨,於減壓下將溶劑蒸餾除去,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對所獲得之殘渣進行精製,而獲得目標化合物18.2g。產率為89%。目標化合物之NMR分析之結果如以下所述。 15.7 g of (2-isopropyl-4-methoxy-5,6-dimethylpyridin-3-yl) methanol and 42.5 g of carbon tetrabromide were dissolved in 300 ml of dichloromethane. After 25.7 g of triphenylphosphine was added at room temperature, it was stirred at room temperature overnight. The reaction solution was washed with sodium bicarbonate water, and the solvent was distilled off under reduced pressure. The obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate), and 18.2 g of the target compound was obtained. The yield was 89%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.29(d,6H),2.17(s,3H),2.47(s,3H),3.31(m,1H), 3.88(s,3H),4.63(s,2H). 1 H-NMR (CDCl 3 , δ ppm) 1.29 (d, 6H), 2.17 (s, 3H), 2.47 (s, 3H), 3.31 (m, 1H), 3.88 (s, 3H), 4.63 (s, 2H).

(步驟4)4-((2-異丙基-4-甲氧基-5,6-二甲基吡啶-3-基)甲基)苯甲腈之合成 (Step 4) Synthesis of 4-((2-isopropyl-4-methoxy-5,6-dimethylpyridin-3-yl) methyl) benzonitrile

將3-(溴甲基)-2-異丙基-4-甲氧基-5,6-二甲基吡啶0.8g、4-氰基苯基硼酸0.647g、碳酸鉀0.608g、四(三苯基膦)鈀0.27g、1,2-二甲氧基乙烷10ml、及水2ml加以混合,進行氬置換後,於氬環境下加熱回流1.5小時。於減壓下將溶劑蒸餾除去,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對所獲得之殘渣進行精製,而獲得目標化合物0.55g。產率為64%。目標化合物之NMR分析之結果如以下所述。 0.8 (g) of 3- (bromomethyl) -2-isopropyl-4-methoxy-5,6-dimethylpyridine, 0.647g of 4-cyanophenylboronic acid, 0.608g of potassium carbonate, 0.27 g of phenylphosphine) palladium, 10 ml of 1,2-dimethoxyethane, and 2 ml of water were mixed and replaced with argon, and then heated under reflux in an argon atmosphere for 1.5 hours. The solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 0.55 g of the target compound. The yield was 64%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.13(d,6H),2.20(s,3H),2.50(s,3H),2.94-3.04(m,1H),3.60(s,3H),4.10(s,2H),7.20(d,2H),7.54(d,2H). 1 H-NMR (CDCl 3 , δ ppm) 1.13 (d, 6H), 2.20 (s, 3H), 2.50 (s, 3H), 2.94-3.04 (m, 1H), 3.60 (s, 3H), 4.10 ( s, 2H), 7.20 (d, 2H), 7.54 (d, 2H).

(步驟5)N-羥基-4-((2-異丙基-4-甲氧基-5,6-二甲基吡啶-3-基)甲基)苯甲脒之合成 (Step 5) Synthesis of N-hydroxy-4-((2-isopropyl-4-methoxy-5,6-dimethylpyridin-3-yl) methyl) benzidine

將4-((2-異丙基-4-甲氧基-5,6-二甲基吡啶-3-基)甲基)苯甲腈5.50g、乙醇100ml、水10ml、羥基胺鹽酸鹽2.61g、及碳酸鈉5.30g加以混合,並加熱 回流4小時。用水稀釋反應液,藉由乙酸乙酯進行萃取,藉由水、飽和食鹽水將所獲得之有機層洗淨,並藉由硫酸鎂加以乾燥。過濾後,於減壓下將溶劑蒸餾除去,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對所獲得之殘渣進行精製,而獲得目標化合物4.20g。產率為69%。目標化合物之NMR分析之結果如以下所述。 5.50 g of 4-((2-isopropyl-4-methoxy-5,6-dimethylpyridin-3-yl) methyl) benzonitrile, 100 ml of ethanol, 10 ml of water, hydroxylamine hydrochloride 2.61 g and 5.30 g of sodium carbonate were mixed and heated under reflux for 4 hours. The reaction solution was diluted with water, extracted with ethyl acetate, and the obtained organic layer was washed with water and saturated brine, and dried over magnesium sulfate. After filtration, the solvent was distilled off under reduced pressure, and the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 4.20 g of the target compound. The yield was 69%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.13(d,6H),2.19(s,3H),2.49(s,3H),2.98-3.08(m,1H),3.60(s,3H),4.10(s,2H),7.10(d,2H),7.50(d,2H). 1 H-NMR (CDCl 3 , δ ppm) 1.13 (d, 6H), 2.19 (s, 3H), 2.49 (s, 3H), 2.98-3.08 (m, 1H), 3.60 (s, 3H), 4.10 ( s, 2H), 7.10 (d, 2H), 7.50 (d, 2H).

(步驟6)2-異丙基-5,6-二甲基-3-(4-(5-(三氟甲基)-1,2,4-二唑-3-基)苄基)吡啶-4-醇之合成 (Step 6) 2-isopropyl-5,6-dimethyl-3- (4- (5- (trifluoromethyl) -1,2,4- Synthesis of Diazol-3-yl) benzyl) pyridin-4-ol

將N-羥基-4-((2-異丙基-4-甲氧基-5,6-二甲基吡啶-3-基)甲基)苯甲脒4.20g溶解於二氯甲烷100ml中,並混合三氟乙酸酐4ml,於室溫下攪拌6小時。於減壓下將溶劑蒸餾除去後,於所獲得之殘渣中添加二甲基甲醯胺60ml,於130℃攪拌20分鐘。於該反應液中混合氯化鋰2.70g、對甲苯磺酸一水合物12.4g,並於130℃攪拌15分鐘。於該反應液中添加碳酸氫鈉8.2g,於室溫下攪拌5分鐘後,用水稀釋並過濾。依序藉由水、二乙醚將所獲得之結晶洗淨,而獲得目標化合物5.20g。產率為90%。目標化合物之NMR分析之結果如以下所述。 Dissolve 4.20 g of N-hydroxy-4-((2-isopropyl-4-methoxy-5,6-dimethylpyridin-3-yl) methyl) benzidine in 100 ml of dichloromethane, 4 ml of trifluoroacetic anhydride were mixed and stirred at room temperature for 6 hours. After the solvent was distilled off under reduced pressure, 60 ml of dimethylformamide was added to the obtained residue, and the mixture was stirred at 130 ° C for 20 minutes. To this reaction solution, 2.70 g of lithium chloride and 12.4 g of p-toluenesulfonic acid monohydrate were mixed, and stirred at 130 ° C for 15 minutes. 8.2 g of sodium bicarbonate was added to the reaction solution, and after stirring at room temperature for 5 minutes, it was diluted with water and filtered. The obtained crystals were sequentially washed with water and diethyl ether to obtain 5.20 g of the target compound. The yield was 90%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.15(d,6H),2.06(s,3H),2.40(s,3H),3.20-3.30(m, 1H),4.11(s,2H),7.35(d,2H),7.97(d,2H). 1 H-NMR (CDCl 3 , δ ppm) 1.15 (d, 6H), 2.06 (s, 3H), 2.40 (s, 3H), 3.20-3.30 (m, 1H), 4.11 (s, 2H), 7.35 ( d, 2H), 7.97 (d, 2H).

(步驟7)2-異丙基-5,6-二甲基-3-(4-(5-(三氟甲基)-1,2,4-二唑-3-基)苄基)吡啶-4-基碳酸甲酯之合成 (Step 7) 2-isopropyl-5,6-dimethyl-3- (4- (5- (trifluoromethyl) -1,2,4- Synthesis of Diazol-3-yl) benzyl) pyridin-4-ylmethyl carbonate

將2-異丙基-5,6-二甲基-3-(4-(5-(三氟甲基)-1,2,4-二唑-3-基)苄基)吡啶-4-醇1.0g溶解於二氯甲烷30ml中,於冰浴冷卻下混合三乙胺2ml、氯甲酸甲酯1ml,並於室溫下攪拌1小時。於減壓下將溶劑蒸餾除去後,藉由矽膠管柱層析法(展開溶劑:正己烷/乙酸乙酯)對所獲得之殘渣進行精製,而獲得目標化合物600mg。產率為52%。目標化合物之NMR分析之結果如以下所述。 Add 2-isopropyl-5,6-dimethyl-3- (4- (5- (trifluoromethyl) -1,2,4- 1.0 g of diazol-3-yl) benzyl) pyridin-4-ol was dissolved in 30 ml of dichloromethane, 2 ml of triethylamine and 1 ml of methyl chloroformate were mixed under cooling in an ice bath, and stirred at room temperature for 1 hour . After the solvent was distilled off under reduced pressure, the obtained residue was purified by silica gel column chromatography (developing solvent: n-hexane / ethyl acetate) to obtain 600 mg of the target compound. The yield was 52%. The results of the NMR analysis of the target compound are as follows.

1H-NMR(CDCl3,δ ppm)1.16(d,6H),2.09(s,3H),2.53(s,3H),3.09-3.19(m,1H),3.73(s,3H),4.04(s,2H),7.23(d,2H),7.99(d,2H). 1 H-NMR (CDCl 3 , δ ppm) 1.16 (d, 6H), 2.09 (s, 3H), 2.53 (s, 3H), 3.09-3.19 (m, 1H), 3.73 (s, 3H), 4.04 ( s, 2H), 7.23 (d, 2H), 7.99 (d, 2H).

將藉由與上述之實施例同樣之方法所製造之化合物之一例示於第1表~第7表中。並且將化合物之物性資料記載於「物性」之欄。作為物性資料,係記載熔點[mp(℃)]、折射率或其性狀。 One of the compounds produced by the same method as the above-mentioned Example is shown in Tables 1-7. The physical properties of the compounds are listed in the "physical properties" column. As the physical property data, the melting point [mp (° C)], the refractive index, or its properties are described.

又,表中,Me表示甲基,Et表示乙基,nPr表示正丙基,iPr表示異丙基,cPr表示環丙基,nBu表示正丁基,iBu表示異丁基,tBu表示三級丁基,cBu表示環丁基,cPen表示環戊基,cHex表示環己基,Ac表示乙醯基,Ph 表示苯基,Bn表示苄基,Py表示吡啶基,PINB表示4,4,5,5-四甲基-1,3,2-二氧硼戊環基。 In the table, Me represents methyl, Et represents ethyl, n Pr represents n-propyl, i Pr represents isopropyl, c Pr represents cyclopropyl, n Bu represents n-butyl, i Bu represents isobutyl, t Bu represents tertiary butyl, c Bu represents cyclobutyl, c Pen represents cyclopentyl, c Hex represents cyclohexyl, Ac represents ethenyl, Ph represents phenyl, Bn represents benzyl, Py represents pyridyl, and PINB Represents 4,4,5,5-tetramethyl-1,3,2-dioxolane.

第1表表示式(1)表示之化合物中之取代基。 Table 1 shows substituents in the compound represented by formula (1).

第2表表示式(2)表示之化合物中之取代基。 Table 2 shows substituents in the compound represented by formula (2).

第3表表示式(3)表示之化合物中之取代基。 Table 3 shows substituents in the compound represented by formula (3).

第4表表示式(4)表示之化合物中之取代基。 Table 4 shows the substituents in the compound represented by formula (4).

第5表表示式(5)表示之化合物中之取代基。 Table 5 shows the substituents in the compound represented by formula (5).

第6表表示式(6)表示之化合物中之取代基。 Table 6 shows substituents in the compound represented by formula (6).

將上述之第1表~第7表中所記載之若干化合物之1H-NMR資料示於第8表中。 Table 1 shows 1 H-NMR data of some of the compounds described in Tables 1 to 7 above.

如以上般,本發明化合物可藉由使用如上述實施例之公知之化學反應而容易地製造。 As described above, the compound of the present invention can be easily produced by using a known chemical reaction as in the above-mentioned examples.

[生物試驗] [Biological test]

藉由以下之試驗例表現出本發明化合物作為農園藝用殺菌劑、殺蟲劑或殺蟎劑之有效成分而有用。 The following test examples show that the compound of the present invention is useful as an active ingredient of agricultural and horticultural fungicides, insecticides, or acaricides.

(試驗例1)小麥白粉病防除試驗 (Experiment example 1) Control test of wheat powdery mildew

將本發明化合物5份、聚氧乙烯山梨醇酐單月桂酸酯1.5份、及二甲基甲醯胺93.5份加以混合,製備有效成分5%之乳劑。以本發明化合物成為125ppm之方式用水稀釋該乳劑,而獲得藥液。 5 parts of the compound of the present invention, 1.5 parts of polyoxyethylene sorbitan monolaurate, and 93.5 parts of dimethylformamide were mixed to prepare an emulsion of 5% as an active ingredient. The emulsion was diluted with water so that the compound of the present invention became 125 ppm to obtain a medicinal solution.

繼而,對在育苗用盆中栽培之小麥幼苗(品種「Chihoku」、1~2葉期)噴灑上述藥液。風乾後,抖粉接種小麥白粉病菌(Erysiphe graminis f.sp.tritici)之分生孢子,靜置於20℃之溫室中。於接種起第6天調查葉上之病斑出現狀態(處理區)。 Then, the above-mentioned medicinal solution was sprayed on the wheat seedlings (variety "Chihoku", 1-2 leaf stage) cultivated in the nursery pot. After air-drying, shaking powder was inoculated with conidia of wheat powdery mildew (Erysiphe graminis f.sp.tritici) and placed in a greenhouse at 20 ° C. On the 6th day after the inoculation, the appearance of disease spots on the leaves (treatment area) was investigated.

另一方面,不噴灑該稀釋溶液而栽培小麥,同樣地調查病斑出現狀態(無處理區)。 On the other hand, wheat was cultivated without spraying the diluted solution, and the appearance of disease spots (non-treated area) was similarly investigated.

藉由下述之式算出以無處理區為基準之防除值。 The control value based on the no-treatment zone was calculated by the following formula.

防除值(%)=100-{出現病斑之面積(處理區)/出現病斑之面積(無處理區)}×100 Control value (%) = 100- {Area where lesions appear (treated area) / Area where lesions appear (non-treated area)) × 100

對第9表所示之化合物進行小麥白粉病防除試驗。任一化合物之防除值均為75%以上。 The compounds shown in Table 9 were tested for wheat powdery mildew control. The control value of any compound is above 75%.

(試驗例2)小麥赤銹病防除試驗 (Experiment example 2) Control test of wheat red rust

藉由與試驗例1相同之方法製備乳劑。以本發明化合物成為125ppm之方式用水稀釋該乳劑,而獲得藥液。 An emulsion was prepared by the same method as in Test Example 1. The emulsion was diluted with water so that the compound of the present invention became 125 ppm to obtain a medicinal solution.

繼而,對在育苗用盆中栽培之小麥幼苗(品種「農林61號」、1~2葉期)噴灑上述藥液。風乾後,抖粉接種小麥赤銹病菌(Puccinia recondita)之夏孢子,靜置於20℃之溫室中。於接種起第12天調查葉上之病斑出現狀態(處理區)。 Then, the above-mentioned medicinal solution was sprayed on a wheat seedling (cultivar "Nonglin 61", 1 to 2 leaf stage) cultivated in a nursery pot. After air-drying, shake powder was inoculated with the summer spores of Puccinia recondita and placed in a greenhouse at 20 ° C. On the 12th day after the inoculation, the appearance of disease spots on the leaves (treatment area) was investigated.

另一方面,不噴灑該稀釋溶液而栽培小麥,同樣地調查病斑出現狀態(無處理區)。 On the other hand, wheat was cultivated without spraying the diluted solution, and the appearance of disease spots (non-treated area) was similarly investigated.

以與試驗例1同樣之方式算出防除值。 The control value was calculated in the same manner as in Test Example 1.

對第10表所示之化合物進行小麥赤銹病防除試驗。任一化合物之防除值均為75%以上。 The compounds shown in Table 10 were tested for wheat rust control. The control value of any compound is above 75%.

(試驗例3)針對黏夜蛾之效力確認試驗 (Test example 3) potency confirmation test against Spodoptera litura

藉由與試驗例1相同之方法,製備有效成分5%之乳劑。 By the same method as in Test Example 1, an emulsion with an active ingredient of 5% was prepared.

將市售之人工飼料(Insecta LFS,日本農產工業公司製造)0.8g與乳劑1μl充分混合,按照各處理區各0.2g之方式裝填至塑膠製試驗容器(容積1.4ml)中而製成試驗用飼料。對各處理區各接種2隻黏夜蛾之2齡幼蟲,以塑膠製之蓋將其密封。將其置於25℃之恆溫室內,於第5天調查殺蟲率與攝食量。將試驗反覆進行2次。又,將除了從乳劑中除去本發明化合物 以外於相同之條件下進行之試驗設為溶劑對照區。殺蟲率係藉由下述之式而算出。 0.8 g of commercially available artificial feed (Insecta LFS, manufactured by Nippon Minko Kogyo Co., Ltd.) was thoroughly mixed with 1 μl of an emulsion, and 0.2 g of each treatment zone was filled into a plastic test container (1.4 ml in volume) to prepare a test With feed. Each treatment area was inoculated with 2 second-instar larvae of Spodoptera exigua, which were sealed with a plastic cover. It was placed in a constant temperature room at 25 ° C, and the insecticidal rate and food intake were investigated on the 5th day. The test was repeated twice. In addition, a test performed under the same conditions except that the compound of the present invention was removed from the emulsion was set as a solvent control zone. The insecticidal rate is calculated by the following formula.

殺蟲率(%)=(死亡蟲數/供試蟲數)×100 Insecticidal rate (%) = (Number of dead insects / Number of test insects) × 100

對第11表所示之化合物進行針對黏夜蛾之效力試驗。任一化合物針對黏夜蛾,殺蟲率為100%或攝食量相對於溶劑對照區之比為10%以下,均有效。 The compounds shown in Table 11 were tested for efficacy against Spodoptera frugiperda. Either compound was effective against Spodoptera exigua, with an insecticidal rate of 100% or a ratio of food intake to the solvent control area of 10% or less.

(試驗例4)針對豆蚜之效力確認試驗 (Experimental Example 4) Efficacy test against bean aphids

藉由與試驗例1相同之方法製備乳劑。以本發明化合物成為125ppm之方式用水稀釋該乳劑,而獲得藥液。 An emulsion was prepared by the same method as in Test Example 1. The emulsion was diluted with water so that the compound of the present invention became 125 ppm to obtain a medicinal solution.

於3寸缽中培育豇豆,在初生葉上接種豆蚜若蟲。對該豇豆苗噴灑上述藥液。將豇豆苗置於溫度25℃、濕度60%之恆溫室內。於噴灑起第4天判定豆蚜之生死,算出殺蟲率。將試驗反覆進行2次。 Cowpeas were cultivated in 3-inch bowls, and the primary leaves were inoculated with bean aphid nymphs. The cowpea seedlings were sprayed with the above medicinal solution. Place cowpea seedlings in a constant temperature room at a temperature of 25 ° C and a humidity of 60%. On the 4th day after spraying, the life and death of the bean aphid were determined, and the insecticidal rate was calculated. The test was repeated twice.

以與試驗例3同樣之方式算出殺蟲率。 The insecticidal rate was calculated in the same manner as in Test Example 3.

對第12表所示之化合物進行針對豆蚜之效力試驗。任一化合物對豆蚜均表現出100%之殺蟲率。 The compounds shown in Table 12 were tested for efficacy against the bean aphid. Each compound showed a 100% insecticidal rate against the bean aphid.

(試驗例5)針對神澤氏葉蟎之效力確認試驗 (Test Example 5) Efficacy Confirmation Test against Tetranychus kanzawa

藉由與試驗例1相同之方法製備乳劑。以本發明化合物成為125ppm之方式用水稀釋該乳劑,而獲得藥液。 An emulsion was prepared by the same method as in Test Example 1. The emulsion was diluted with water so that the compound of the present invention became 125 ppm to obtain a medicinal solution.

於3寸缽中培育四季豆,在初生葉上接種10隻神澤氏葉蟎雌性成蟲。對該四季豆苗噴灑上述藥液。將四季豆苗置於溫度25℃、濕度65%之恆溫室內。於噴灑起第10天判定神澤氏葉蟎成蟲之生死,算出殺蟲率。將試驗反覆進行2次。 The green beans were cultivated in a 3-inch bowl, and 10 female adults of the spider mite, Kanzawa, were inoculated on the primary leaves. The medicinal solution was sprayed on the green bean sprouts. Place green bean sprouts in a constant temperature room at a temperature of 25 ° C and a humidity of 65%. On the 10th day after spraying, the life and death of the adult spider mite, Kanzawa, was determined, and the insecticidal rate was calculated. The test was repeated twice.

以與試驗例3同樣之方式算出殺蟲率。 The insecticidal rate was calculated in the same manner as in Test Example 3.

對第13表所示之化合物進行針對神澤氏葉蟎之效力試驗。任一化合物對神澤氏葉蟎均表現出100%之殺蟲率。 The compounds shown in Table 13 were tested for potency against Tetranychus kanzawa. Each compound showed a 100% insecticidal rate against Tetranychus sinensis.

從本發明化合物中隨機選擇者均發揮出如上述之效果,因此可理解,包括未完全例示之化合物在內,本發明化合物係具有有害生物防除、殺菌、殺蟎、殺蟲等效果,不會對植物體產生藥害,且對人畜魚類之毒性或對環境之影響少之化合物。 Those who are randomly selected from the compounds of the present invention exhibit the above-mentioned effects. Therefore, it can be understood that the compounds of the present invention have the effects of pest control, sterilization, acaricide, insecticide, etc. Compounds that cause phytotoxicity to plants and have little toxicity to humans, animals, fish, or the environment.

[產業上之可利用性] [Industrial availability]

本發明之吡啶化合物係具有有害生物防除、殺菌、殺蟎、殺蟲等效果,不會對植物體產生藥害,對人畜魚類之毒性或對環境之影響少的新穎化合物。尤其是對麥類病害表現出優異之防除效果。本發明之吡啶化合物作為農園藝用殺菌劑、有害生物防除劑、及殺蟲或殺蟎劑之有效成分而有用,可於產業上利用。 The pyridine compound of the present invention is a novel compound that has the effects of pest control, sterilization, acaricide, insecticide, etc., does not cause phytotoxicity to plants, and has little toxicity to humans, animals, fish, and the environment. In particular, it shows excellent control effects on wheat diseases. The pyridine compound of the present invention is useful as an active ingredient of agricultural and horticultural fungicides, pest control agents, and insecticides or acaricides, and can be used industrially.

Claims (5)

一種吡啶化合物、其N-氧化物化合物、或者其互變異構物或鹽,該吡啶化合物係以式(I)表示, 式(I)中,R 1表示氫原子、未經取代或經G 1取代之C1~6烷基、未經取代或經G 1取代之C2~6烯基、未經取代或經G 1取代之C1~6烷氧基、未經取代或經G 1取代之C1~6烷氧基羰基、未經取代或經G 1取代之C1~6烷硫基(alkylthio group)、未經取代或經G 1取代之C1~6烷基胺基羰基、未經取代或經G 2取代之C6~10芳基、氰基或鹵素基(halogeno group),式(I)中,R 2表示氫原子、未經取代或經G 1取代之C1~6烷基、未經取代或經G 1取代之C2~6烯基、未經取代或經G 2取代之C3~8環烷基、未經取代或經G 1取代之C1~6烷氧基、甲醯氧基、未經取代或經G 1取代之C1~6烷基羰氧基、未經取代或經G 2取代之C6~10芳基、(未經取代或經G 1取代之C1~6烷氧基亞胺基)-C1~6烷基、未經取代或經G 2取代之3~10員雜環基C1~6烷基、氰基或鹵素基,式(I)中,R 3表示氫原子、未經取代或經G 1取代之C1~6烷基、未經取代或經G 1取代之C2~6烯基、未經取代或經G 2取代之C3~8環烷基、未經取代或經G 1取代之C1~6烷氧基、未經取代或經G 1取代之 C1~6烷基羰基、未經取代或經G 1取代之C1~6烷氧基羰基、羧基、甲醯基、甲醯氧基、未經取代或經G 1取代之C1~6烷基羰氧基、未經取代或經G 2取代之C6~10芳基、未經取代或經G 2取代之3~10員雜環基、(未經取代或經G 1取代之C1~6烷氧基亞胺基)-C1~6烷基、未經取代或經G 1取代之單C1~6烷基胺基、未經取代或經G 1取代之二C1~6烷基胺基、氰基或鹵素基,式(I)中,R 4表示氫原子、未經取代或經G 1取代之C1~6烷基、未經取代或經G 1取代之C2~6烯基、未經取代或經G 1取代之C2~6炔基、未經取代或經G 2取代之C3~8環烷基、未經取代或經G 2取代之C6~10芳基C1~6烷基、未經取代或經G 2取代之3~10員雜環基C1~6烷基、甲醯基、未經取代或經G 1取代之C1~6烷基羰基、未經取代或經G 2取代之C3~8環烷基羰基、未經取代或經G 1取代之C2~6烯基羰基、未經取代或經G 2取代之C6~10芳基羰基、未經取代或經G 1取代之C1~6烷氧基羰基、未經取代或經G 1取代之C2~6烯氧基羰基、未經取代或經G 1取代之C1~6烷基磺醯基、未經取代或經G 1取代之C1~6烷基胺基羰基、未經取代或經G 1取代之(C1~6烷硫基)羰基、未經取代或經G 1取代之C1~6烷基胺基(硫羰基)、或者式(II)表示之有機基, 式(II)中,*表示鍵結鍵, 式(II)中,G a分別獨立地表示氫原子、未經取代或經G 1取代之C1~6烷基、未經取代或經G 1取代之C2~6烯基、未經取代或經G 1取代之C2~6炔基、未經取代或經G 2取代之C3~8環烷基、或者未經取代或經G 2取代之C6~10芳基,式(II)中,G b表示氫原子、未經取代或經G 1取代之C1~6烷基、未經取代或經G 1取代之C2~6烯基、未經取代或經G 1取代之C2~6炔基、未經取代或經G 2取代之C3~8環烷基、未經取代或經G 2取代之C6~10芳基、或者未經取代或經G 2取代之3~10員雜環基,式(II)中,T表示氧原子、氧基羰基、羰氧基、氧基羰氧基、硫原子、(硫基)羰基、羰基(硫基)、(硫基)羰氧基、氧基羰基(硫基)或-O-C(=O)-N(G b)-表示之二價基,式(I)中,A表示氧原子或式(III)表示之二價有機基, 式(III)中,*表示鍵結位置,式(III)中,R 5及R 6分別獨立地表示氫原子、未經取代或經G 1取代之C1~6烷基、未經取代或經G 1取代之C1~6烷氧基、未經取代或經G 2取代之C6~10芳氧基、未經取代或經G 1取代之烷氧基羰氧基、鹵素基、羥基,R 5及R 6可相連而與R 5及R 6所鍵結之碳原子一起形成3~6員環, 式(I)中,Cy表示未經取代或經G 2取代之C6~10芳基、經G 2取代之C3~8環烷基、未經取代或經G 2取代之3~10員雜環基、或13員雜芳基,G 1表示羥基、C1~6烷氧基、C1~6烷氧基C1~6烷氧基、C1~6烷氧基羰基、甲醯氧基、C1~6烷基羰氧基、C1~6烷氧基羰氧基、單C1~6烷氧基羰基胺基、氰基、胺基或鹵素基,於經G 1取代之基存在2個以上之情形時,該G 1互相可相同,亦可不同,G 2表示未經取代或經G 21取代之C1~8烷基、未經取代或經G 21取代之C2~6烯基、未經取代或經G 21取代之C2~6炔基、羥基、未經取代或經G 21取代之C1~6烷氧基、甲醯基、未經取代或經G 21取代之C1~6烷基羰基、未經取代或經G 21取代之C1~6烷氧基羰基、甲醯氧基、未經取代或經G 21取代之C1~6烷基羰氧基、甲醯基胺基、未經取代或經G 21取代之單C1~6烷基羰基胺基、未經取代或經G 21取代之N-(C1~6烷基羰基)-N-(C1~6烷基)胺基、未經取代或經G 21取代之N-(C1~6烷基羰基)-N-(C1~6烷氧基羰基)胺基、未經取代或經G 21取代之C1~6烷氧基羰氧基、未經取代或經G 21取代之單C1~6烷氧基羰基胺基、未經取代或經G 22取代之C3~8環烷基、未經取代或經G 22取代之C3~8環烯基、未經取代或經G 22取代之C3~8環烷基羰基胺基羰基、未經取代或經G 22取代之C6~10芳基、未經取代或經G 22取代之C6~10芳基C2~6炔基、未經取代或經G 22取代之C6~10芳氧基、未經取代或經G 22取代之3~10員雜環基、13員雜芳基、未經取代或經G 22取代之3~10員雜環氧基、巰基、未經取代或經G 21取代之C1~6烷硫基、未經取代或經 G 21取代之C1~6烷基亞磺醯基、未經取代或經G 21取代之C1~6烷基磺醯基、五氟硫基(pentafluorosulfanyl group)、未經取代或經G 22取代之C6~10芳硫基、未經取代或經G 22取代之C6~10芳基亞磺醯基、未經取代或經G 22取代之C6~10芳基磺醯基、未經取代或經G 22取代之單C6~10芳基胺基、二氫氧硼基(dihydroboryl group)、硝基、氰基、鹵素基、未經取代或經G 21取代之C1~6伸烷基(alkylene group)、未經取代或經G 21取代之C1~6伸烷基單氧基、未經取代或經G 21取代之C1~6伸烷基二氧基、-CR a=NR b表示之基,此處,R a表示氫原子、C1~6烷基、未經取代或經G 21取代之單C1~6烷基羰基胺基、或者未經取代或經G 22取代之單C3~8環烷基羰基胺基,R b表示未經取代或經G 21取代之C1~6烷氧基、未經取代或經G 22取代之C3~8環烷氧基、未經取代或經G 22取代之苯氧基、未經取代或經G 21取代之單C1~6烷基胺基、或者未經取代或經G 21取代之二C1~6烷基胺基,於經G 2取代之基存在2個以上之情形時,該G 2互相可相同,亦可不同,G 21表示C1~6烷氧基、C1~6鹵化烷氧基、單C1~6烷基胺基、二C1~6烷基胺基、單(C1~6烷氧基C1~6烷基羰基)胺基、未經取代或經G 211取代之C6~10芳基、未經取代或經G 211取代之C6~10芳氧基、未經取代或經G 211取代之3~10員雜環基、未經取代或經G 211取代之3~10員雜環氧基或鹵素基,於經G 21取代之基存在2個以上之情形時,該G 21互相可相同,亦可不同,G 211表示C1~6烷基、C1~6鹵化烷基、C1~6烷氧基、C1~6鹵化 烷氧基或鹵素基,於經G 211取代之基存在2個以上之情形時,該G 211互相可相同,亦可不同,G 22表示未經取代或經羥基取代之C1~6烷基、C1~6鹵化烷基、C2~6烯基、C2~6鹵化烯基、C2~6炔基、C1~6烷氧基、C1~6鹵化烷氧基、C1~6烷基羰基、單C1~6烷基胺基、二C1~6烷基胺基、C1~6烷基胺基羰基、C1~6烷硫基、C1~6鹵化烷硫基、C1~6烷基亞磺醯基、C1~6鹵化烷基亞磺醯基、C1~6烷基磺醯基、C1~6鹵化烷基磺醯基、未經取代或經G 221取代之C3~8環烷基、未經取代或經G 221取代之C3~8環烷基C1~6烷基、未經取代或經G 221取代之C6~10芳基、未經取代或經G 221取代之3~10員雜環基、未經取代或經G 221取代之3~10員雜環基羰基、五氟硫基、硝基、氰基、鹵素基、側氧基、未經取代或經G 211取代之C1~6伸烷基二氧基、或-CR c=NOR d表示之基,此處,R c表示C1~6烷基,R d表示未經取代或經G 221取代之C3~8環烷基,於經G 22取代之基存在2個以上之情形時,該G 22互相可相同,亦可不同,G 221表示C1~6烷基、C1~6鹵化烷基、C1~6烷氧基、C1~6鹵化烷氧基、單C1~6烷基胺基、二C1~6烷基胺基、C6~10芳基或鹵素基,於經G 221取代之基存在2個以上之情形時,該G 221互相可相同,亦可不同。 A pyridine compound, an N-oxide compound thereof, or a tautomer or salt thereof, the pyridine compound is represented by formula (I), In formula (I), R 1 represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1 to 6 alkyl group, an unsubstituted or G 1 substituted C 2 to 6 alkenyl group, an unsubstituted or G 1 substituted C1 ~ 6 alkoxy, unsubstituted or G 1 substituted C1 ~ 6 alkoxycarbonyl, unsubstituted or G 1 substituted C1 ~ 6 alkylthio group, unsubstituted or G 1 substituted C1 ~ 6 alkylaminocarbonyl, unsubstituted or G 2 substituted C6 ~ 10 aryl, cyano or halogeno group, in formula (I), R 2 represents a hydrogen atom, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl, unsubstituted or substituted with G 1 of C2 ~ 6 alkenyl, unsubstituted or substituted with G 2 of C3 ~ 8 cycloalkyl, unsubstituted or C1 ~ 6 alkoxy substituted with G 1 , methyloxy, unsubstituted or substituted G 1-6 alkylcarbonyloxy, unsubstituted or substituted G 2- C 6-10 aryl, (C1-C6 alkoxyimino group, unsubstituted or substituted with G 1 ) -C1-6 alkyl group, 3 to 10-membered heterocyclic C1- 6 alkyl group, unsubstituted or G 2 substituted, cyano group or a halogen group, in the formula (I), R 3 represents a hydrogen atom, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl, unsubstituted or substituted with G 1 of C2 ~ 6 alkenyl , Unsubstituted or substituted with G 2 of C3 ~ 8 cycloalkyl, unsubstituted or substituted with G 1 of C1 ~ 6 alkoxy, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl-carbonyl group, an C1 ~ 6 alkoxycarbonyl, substituted with or substituted with G 1 , carboxyl, formamyl, formyloxy, unsubstituted or substituted with G 1 -C 6 alkylcarbonyloxy, G 2 substituted C6 ~ 10 aryl, unsubstituted or G 2 substituted 3 ~ 10 membered heterocyclyl, (unsubstituted or G 1 substituted C1 ~ 6 alkoxyimino) -C1 ~ 6 alkyl, unsubstituted or G 1 substituted mono C1 ~ 6 alkylamino, unsubstituted or G 1 substituted C1 ~ 6 alkylamino, cyano or halogen group, formula (I) In the formula, R 4 represents a hydrogen atom, an unsubstituted or G 1 substituted C1 to 6 alkyl group, an unsubstituted or G 1 substituted C 2 to 6 alkenyl group, an unsubstituted or G 1 substituted C 2 to 6 Alkynyl, unsubstituted or G 2 substituted C3 ~ 8 cycloalkyl, unsubstituted or G 2 substituted C6 ~ 10 aryl C1 ~ 6 alkyl, unsubstituted or G 2 substituted 3 ~ 10-membered heterocyclyl C1-6 alkyl, formamyl, unsubstituted or G 1 substituted C1-6 alkylcarbonyl, unsubstituted or G 2 substituted C3-8 cycloalkylcarbonyl Group, unsubstituted or G 1 substituted C2-6 alkenylcarbonyl, unsubstituted or G 2 substituted C6-10 arylcarbonyl, unsubstituted or G 1 substituted C1-6 alkoxycarbonyl , unsubstituted or G 1 of C2 ~ 6 alkenyl substituted oxycarbonyl group, unsubstituted or substituted with G 1 of C1 ~ 6 alkylsulfonyl group, unsubstituted or substituted with G 1 of C1 ~ 6 alkyl aminocarbonyl, unsubstituted or substituted with 1 G of (C1 ~ 6 alkylthio) carbonyl group, a substituted or unsubstituted of C1 ~ 6 alkylamino (thiocarbonyl group) by G, or of formula (II), Organic base, In formula (II), * represents a bonding bond, and in formula (II), G a each independently represents a hydrogen atom, an unsubstituted or G 1 -substituted C1 to 6 alkyl group, unsubstituted or substituted with G 1 C2 ~ 6 alkenyl, unsubstituted or G 1 substituted C2 ~ 6 alkynyl, unsubstituted or G 2 substituted C3 ~ 8 cycloalkyl, or unsubstituted or G 2 substituted C6 ~ 10 aryl group, in the formula (II), G b represents a hydrogen atom, an unsubstituted or G 1 -substituted C 1 to 6 alkyl group, an unsubstituted or G 1 substituted C 2 to 6 alkenyl group, an unsubstituted or substituted by G 1 group of C2 ~ 6 alkynyl, unsubstituted or substituted with G 2 of C3 ~ 8 cycloalkyl, unsubstituted or substituted with G 2 of the C6 ~ 10 aryl group, or unsubstituted or G 2 A substituted 3 to 10-membered heterocyclic group. In the formula (II), T represents an oxygen atom, an oxycarbonyl group, a carbonyloxy group, an oxycarbonyloxy group, a sulfur atom, a (thio) carbonyl group, a carbonyl group (thio), (Thio) carbonyloxy, oxycarbonyl (thio), or a divalent group represented by -OC (= O) -N (G b )-, in formula (I), A represents an oxygen atom or formula (III) Represents a divalent organic group, In formula (III), * represents a bonding position, and in formula (III), R 5 and R 6 each independently represent a hydrogen atom, an unsubstituted or G 1 -substituted C1 to 6 alkyl group, an unsubstituted or G 1 substituted C1 ~ 6 alkoxy, unsubstituted or G 2 substituted C6 ~ 10 aryloxy, unsubstituted or G 1 substituted alkoxycarbonyloxy, halo, hydroxyl, R 5 And R 6 may be connected to form a 3 to 6-membered ring together with the carbon atoms bonded by R 5 and R 6. In the formula (I), Cy represents an unsubstituted or G 2 substituted C 6 to 10 aryl group, G 2 substituted C3-8 cycloalkyl, unsubstituted or G 2 substituted 3-10 member heterocyclic group, or 13-membered heteroaryl group, G 1 represents hydroxyl, C1-6 alkoxy, C1-6 Alkoxy C1 ~ 6 alkoxy, C1 ~ 6 alkoxycarbonyl, formamyloxy, C1 ~ 6 alkylcarbonyloxy, C1 ~ 6 alkoxycarbonyloxy, mono C1 ~ 6 alkoxycarbonyl Amino, cyano, amino or halogen groups, when there are two or more G 1 substituted groups, the G 1 may be the same as or different from each other, and G 2 represents an unsubstituted or G 21 substituted group. C1 ~ 8 alkyl, unsubstituted or G 21 substituted C2-6 alkenyl, unsubstituted or G 21 substituted C2-6 alkynyl, hydroxyl, unsubstituted Unsubstituted or substituted by G of 21 C1 ~ 6 alkoxy, methyl acyl, unsubstituted or substituted with G 21 of C1 ~ 6 alkyl carbonyl, unsubstituted or substituted with G 21 of C1 ~ 6 alkoxycarbonyl Methylformyloxy, unsubstituted or G 21 substituted C1 ~ 6 alkylcarbonyloxy, methylamino, unsubstituted or substituted with G 21 mono C1 ~ 6 alkylcarbonylamino, unsubstituted substituted or unsubstituted by the G 21 N- (C1 ~ 6 alkyl-carbonyl) -N- (C1 ~ 6 alkyl) amino, unsubstituted or substituted with the G 21 N- (C1 ~ 6 alkyl-carbonyl group) -N- (C1 ~ 6alkoxycarbonyl) amino, unsubstituted or substituted with G 21 C1 ~ 6alkoxycarbonyloxy, unsubstituted or substituted with G 21 mono C1 ~ 6 alkoxy carbonyl group, unsubstituted or substituted with the G 22 C3 ~ 8 cycloalkyl, unsubstituted or substituted by the G 22 C3 ~ 8 cycloalkenyl group, unsubstituted or substituted by G 22 of C3 ~ 8 cycloalkyl Carbonylcarbonylaminocarbonyl, unsubstituted or substituted with G 22 C6 ~ 10 aryl, unsubstituted or substituted with G 22 C6 ~ 10 aryl C2 ~ 6 alkynyl, unsubstituted or substituted with G 22 C6 ~ 10 aryloxy, unsubstituted or substituted with the G 22 3 ~ 10 membered heterocyclic group, 13 heteroaryl, unsubstituted or substituted by the G 22 3 ~ 10 membered heteroaryl epoxy , A mercapto group, unsubstituted or substituted with G 21 of C1 ~ 6 alkylthio, unsubstituted or substituted by G of 21 C1 ~ 6 alkylsulfinyl acyl, unsubstituted or substituted with the C1 ~ 6 G 21 Alkylsulfonyl, pentafluorosulfanyl group, unsubstituted or substituted with G 22 C6 ~ 10 arylthio, unsubstituted or substituted with G 22 C6 ~ 10 arylsulfinyl, the unsubstituted or substituted by G 22 C6 ~ 10 aryl sulfonic acyl, unsubstituted or substituted with the single G 22 C6 ~ 10 aryl group, two hydroxyl groups boron (dihydroboryl group), a nitro group, a cyano Group, halo group, unsubstituted or substituted with G 21 C1-6 alkylene group, unsubstituted or substituted with G 21 C1-6 alkylene monooxy, unsubstituted or substituted with G 21- substituted C1 ~ 6 alkylenedioxy, -CR a = NR b represents a group, where R a represents a hydrogen atom, C1 ~ 6 alkyl, unsubstituted or mono-C1 ~ substituted with G 21 6 alkylcarbonylamino, or mono-C3-8 cycloalkylcarbonylamino unsubstituted or substituted with G 22 , R b represents unsubstituted or G 21 substituted C1-6 alkoxy, unsubstituted or substituted of G 22 C3 ~ 8 cycloalkoxy, unsubstituted or substituted by G 22 Phenoxy, unsubstituted or substituted with G 21 of the single-C1 ~ 6 alkyl group, or an unsubstituted or substituted bis G 21 C1 ~ 6 alkyl group, G 2 substituents on the group by the presence of 2 In more than one case, the G 2 may be the same as or different from each other. G 21 represents a C1 to 6 alkoxy group, a C1 to 6 halogenated alkoxy group, a mono C1 to 6 alkylamino group, and a di C1 to 6 alkyl group. Amine, mono (C1 ~ 6alkoxyC1 ~ 6alkylcarbonyl) amino, unsubstituted or substituted with G 211 C6 ~ 10 aryl, unsubstituted or substituted with G 211 C6 ~ 10 aryloxy group, unsubstituted or substituted with the G 211 3 ~ 10 membered heterocyclic group, the unsubstituted or substituted by G 211 3 ~ 10 membered heterocyclic group or a halogen group, G 21 substituents on the group by the presence of two In the above cases, the G 21 may be the same as or different from each other. G 211 represents a C1 to 6 alkyl group, a C1 to 6 halogenated alkyl group, a C1 to 6 alkoxy group, a C1 to 6 halogenated alkoxy group, or a halogen group. When there are two or more groups substituted with G 211 , the G 211 may be the same as or different from each other. G 22 represents an unsubstituted or hydroxy-substituted C1 to 6 alkyl group, C1 to 6 halogenated alkyl group, C2 ~ 6 alkenyl, C2 ~ 6 halogenated alkenyl, C2 ~ 6 alkynyl, C1 ~ 6 alkoxy, C1 ~ 6 halogenated alkoxy C1 ~ 6 alkylcarbonyl, mono C1 ~ 6 alkylamino, di C1 ~ 6 alkylamino, C1 ~ 6 alkylamino carbonyl, C1 ~ 6 alkylthio, C1 ~ 6 halogenated alkylthio, C1 ~ 6 alkylsulfinyl sulfenyl, C1 ~ 6 halogenated alkylsulfinyl sulfonyl, C1 ~ 6 alkylsulfinyl sulfonyl, C1 ~ 6 halogenated alkylsulfinyl sulfonyl, C3 ~ unsubstituted or substituted with G 221 ~ 8 cycloalkyl, unsubstituted or substituted with G 221 C3 ~ 8 cycloalkyl C1 ~ 6 alkyl, unsubstituted or substituted with G 221 C6 ~ 10 aryl, unsubstituted or substituted with G 221 3- to 10-membered heterocyclyl, unsubstituted or substituted with G 221 3- to 10-membered heterocyclylcarbonyl, pentafluorothio, nitro, cyano, halo, pendant, unsubstituted or G 211 group of substituted C1 ~ 6 alkylene dioxy group, or represents -CR c = NOR d of, where, R c represents a C1 ~ 6 alkyl group, R d represents an unsubstituted or substituted by C3 ~ G 221 of 8-cycloalkyl, when there are two or more groups substituted with G 22 , the G 22 may be the same as or different from each other, G 221 represents a C1 to 6 alkyl group, a C1 to 6 halogenated alkyl group, or C1 to 6 Alkoxy, C1 ~ 6 halogenated alkoxy, mono-C1 ~ 6 alkylamino, di-C1 ~ 6 alkylamino, C6 ~ 10 aryl or halogen group, existing in the group substituted with G 221 2 In more than one case, the G 221 may be the same as or different from each other. 一種農園藝用殺菌劑,其含有選自由申請專利範圍第1項之吡啶化合物、其N-氧化物化合物、以及其互變異構物及鹽組成之群中之至少一者作為有效成分。     A fungicide for agriculture and horticulture, comprising as an active ingredient at least one selected from the group consisting of a pyridine compound, an N-oxide compound, and a tautomer and a salt thereof in the first patent application.     一種有害生物防除劑,其含有選自由申請專利範圍第1項之吡啶化合 物、其N-氧化物化合物、以及其互變異構物及鹽組成之群中之至少一者作為有效成分。     A pest control agent comprising, as an active ingredient, at least one selected from the group consisting of a pyridine compound, an N-oxide compound thereof, and a tautomer and a salt thereof in the scope of patent application.     一種殺蟲或殺蟎劑,其含有選自由申請專利範圍第1項之吡啶化合物、其N-氧化物化合物、以及其互變異構物及鹽組成之群中之至少一者作為有效成分。     An insecticidal or acaricide comprising as an active ingredient at least one selected from the group consisting of a pyridine compound, an N-oxide compound thereof, and a tautomer and a salt thereof in the scope of patent application No. 1.     一種外部寄生蟲防除劑,其含有選自由申請專利範圍第1項之吡啶化合物、其N-氧化物化合物、以及其互變異構物及鹽組成之群中之至少一者作為有效成分。     An external parasite controlling agent containing at least one selected from the group consisting of a pyridine compound, an N-oxide compound, and a tautomer and a salt thereof in the scope of claim 1 as an active ingredient.    
TW106124227A 2017-07-20 2017-07-20 Pyridine compound and its use TW201908303A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW106124227A TW201908303A (en) 2017-07-20 2017-07-20 Pyridine compound and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW106124227A TW201908303A (en) 2017-07-20 2017-07-20 Pyridine compound and its use

Publications (1)

Publication Number Publication Date
TW201908303A true TW201908303A (en) 2019-03-01

Family

ID=66590023

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106124227A TW201908303A (en) 2017-07-20 2017-07-20 Pyridine compound and its use

Country Status (1)

Country Link
TW (1) TW201908303A (en)

Similar Documents

Publication Publication Date Title
JP5281647B2 (en) Nitrogen-containing heterocyclic compounds and salts thereof, and agricultural and horticultural fungicides
BR112017005410B1 (en) Isoxazoline ring-containing uracil compounds and uses thereof
KR20120088000A (en) Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide
JP2014166991A (en) Nitrogen-containing heterocyclic compound and agricultural and horticultural bactericidal agent
JPWO2003000686A1 (en) Isoxazoline derivatives and herbicides
JP6413200B2 (en) Aminopyridine derivatives and agricultural and horticultural fungicides
JPH0532662A (en) Substituted pyrazole derivative and agricultural and horticultural fungicide
JP6837052B2 (en) Pyridine compounds and their uses
DE69931623T2 (en) Pyrazolinone DERIVATIVES
JP2000226374A (en) Pyrazolinone derivative
EP1408027A1 (en) DIAMINE DERIVATIVE,PROCESS FOR PRODUCING THE SAME, AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT
JPH0665237A (en) Substituted pyrazole derivative and germicide for agriculture and horticulture
JP2019523299A (en) Novel benzylamide compound, method for producing the same, and acaricide
WO2013075645A1 (en) 6-substituted phenyl quinazolone compound and use thereof
JP2017206440A (en) Pyridine compound and use therefor
JPS63225364A (en) Aralkylaminopyrimidine derivative, its production and insecticide, miticide and fungicide containing said derivative as active component
TW201908303A (en) Pyridine compound and its use
JPH02311477A (en) Sulfonamide
JP2016164126A (en) Aminopyridine derivative and agricultural and horticultural insecticide
WO1996017841A1 (en) Pyridylpyrrole compounds, process for production, and agrohorticultural bactericide
JP2762505B2 (en) Condensed heterocyclic derivative, production method and herbicide
JP3366715B2 (en) Aminopyrimidine derivatives, their production method and intermediates for production, and agricultural fungicides, insecticides and acaricides containing the same
WO2014115834A1 (en) Azolyl oxime compound or salt thereof, pest-control agent, insecticide or acaricide, disinfectant, and external parasite control agent
JP2016030742A (en) Azolyloxime compound, and pest control agent, insecticide or miticide, sterilization agent, and ectoparasite control agent comprising the same as active ingredient
JP2011236197A (en) Tetrazolyl compound or salt thereof and germicide